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INTRODUCTION
Consumer demand for dietary foods and beverages has risen sharply
in recent years as a direct result of rapidly increasing numbers of
calorie conscious individuals. More than 68 million Americans, age 18
and over, are currently using low-calorie foods and beverages; of this
total, over 50 million consumers use aspartame-sweetened products
regularly (1).
In considering the total population of weight-conscious Americans,
an increasing number of this total are utilizing exercise as a method
of weight control. It is reasonable to assume that many of these "ex-
ercisers" also incorporate or will incorporate the use of the low-calorie
sweetener aspartame (4 kcal/g) in their diets as an added measure of
weight control. It is therefore important to determine the physiological
interaction between aspartame and exercise.
The purpose of this study was to determine if aspartame supplemented
rats responded to exercise differently than those not fed aspartame.
This objective was accomplished by comparisons within a 2 x 2 factorial
design (n=9) where the main treatment effects were treadmill exercise
and aspartame. Feed intake, weight gain, body composition, percent body
fat and serum lipid levels were measured. It is hoped that information
from the study will lead to a better understanding of the physiological
consequences of combining exercise and aspartame use as a method for
weight control.
REVIEW OF LITERATURE
I. Use of Aspartame in Foods
Chemical Composition of Aspartame . Aspartame (N-L-a-aspartyl-L-
phenylalanine methyl ester) is a dipeptide ester containing the amino
acids aspartic acid and phenylalanine. A methyl group is esterified to
the carboxyl group of the phenylalanine (Fig. 1). The chemical nature
of aspartame, being similar to that of normal dietary protein, allows it
to enter normal metabolic pathways where it is oxidized for energy via
oxidative metabolism and the tricarboxylic acid cycle or broken down for
utilization in other biosynthetic reactions (Fig. 2) (2).
Physical Properties and Sweetness . Aspartame is an odorless, white,
water-soluble powder. Solubility increases in acid and/or warm solutions.
It has no bitter aftertaste and is approximately 180 to 200 times sweeter
than an equal weight of sucrose. Aspartame in powder (dry) form is stable
at temperatures up to 40 C. (104 F) for over a year. In solution, however,
gradual decomposition occurs, resulting in breakdown to its diketopipera-
zine form and a subsequent reduction in sweetness. Decomposition is slow
in acid solutions and more rapid in alkaline ones. The maximum stability
of aspartame in solution is at pH 3.9 to 4.3. Twenty percent of its sweet-
ness is lost in four and a half months at a pH of 4 (that of some soft
drinks) at 20 C (68 F) . In neutral solutions half the sweetness can be
lost in hours.
Utility as a Nutritive Sweetener . Aspartame (commercially known as
NutraSweet) is currently being utilized as a table top sweetener with the
brand name of Equal as well as a sugar substitute in soft drinks, dry
beverage mixes, presweetened cereals, gelatins, puddings and fillings,
chewing gum, and flavored coffees. Its role as a sweetener is limited to
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foods that do not require extensive cooking because sweetness decreases
as aspartame hydrolyzes at high temperatures. Use in baked goods such
as cakes, cookies and bread is restricted by its lack of bulk and struc-
ture. Also, it is not useful for sweetening nonacid liquids that are
stored for long periods of time.
Current Consumption . With the rapid increase in numbers of calorie
conscious Americans in recent years, there has been a concurrent growth
in consumer demand for dietary foods and beverages. Over 50 million con-
sumers use aspartame-sweetened products regularly (1) . Tbis consumption
is not exclusively by consumers desiring to replace other sugar substi-
tutes in the diet. Approximately 60% of Equal users did not previously
use low-calorie tabletop sweeteners (3). This statistic suggests that
sugar users are now some of Equal's best customers.
If all sucrose in the diet was replaced by aspartame, average con-
sumption by a 60 kg (132 lb) person would be approximately 8.3 mg/kg body
weight of aspartame per day, according to FDA estimates (4) . Estimates of
potential aspartame exposure were also derived from a study by the Market
Research Corporation of America (MRCA) (5) . In that study, food consump-
tion data were gathered by MRCA from 12,337 individuals in 4000 house-
holds. Consumption of food products (both in-home and away-from-home) was
recorded over randomly-spaced two-week periods for one year. The data
thus presented an accurate estimate of what Americans actually eat. To
project aspartame consumption, it was assumed that aspartame replaced sugar
and other sweeteners in 30 product categories representing reasonable
commercial uses of aspartame (including carbonated beverages). An intake
of 34 mg/kg body weight was determined to represent the 99th percentile of
potential theoretical daily usage exposure for all age groups combined.
II. Metabolism of Aspartame in Humans and Animals
Digestion and Absorption . Unlike non-nutritive sweeteners such as
saccharin, aspartame is a nutritive sweetener and therefore enters normal
metabolic pathways. Its components are either oxidized for energy or
utilized in other biosynthetic reactions. Hydrolysis by esterases of the
intestinal lumen yields the phenylalanine-aspartic acid dipeptide and
methanol. The dipeptide is then converted by mucosal dipeptidases into
its free amino acids. The methanol, phenylalanine and aspartic acid
breakdown products are absorbed and metabolized by entering their usual
metabolic pathways.
In a study on the metabolism of aspartame in monkeys, Ranney et
14
al. (6) compared the metabolism of ( C) aspartame labeled separately in
the methyl, aspartyl and phenylalanine moieties to the metabolism of C-
labeled methanol, aspartic acid, and phenylalanine. Each aspartame moiety
was metabolized the same as its free counterpart, leading to the conclusion
that aspartame was digested to its three components which were then ab-
sorbed as normal dietary constituents. A specific decription of the me-
tabolism of each aspartame component follows.
Aspartic Acid Metabolism . Aspartic acid, one of the dicarboxylic
amino acids, plays an important role in nitrogen and energy metabolism in
the mitochondria. As illustrated in Figure 3, aspartate joins glutamate,
the other dicarboxylic amino acid, in representing a major entry point to
the tricarboxylic acid cycle (6).
The major pathway of free aspartic acid is its transamination with
other a-ketoacids to produce oxaloacetic acid, an intermediate of the
Krebs Cycle.
A vr aspartate transaminase n . „,,„„„„»_Asp + ct-KG c > OAA + L-elutamate
1
KREBS
CYCLE
Glucose
Pentose phosphate
Oxaloacetate
» Hexose phosphates
t
Glycerol phosphates
t
-
Phpsphoenaipyri
Oxaloacetaie + Acety'-CoA
CO. * NH, t- ATP
Carbamyi phosphatF
Aspartate
, Curulline
Argininosuccinate
Fig. 3 Role of aspartic acxu in nitrogen and energy
metabolism. Ranney et al. (C\ .
14
Ranney et al. (6} showed that the resulting C0 2 excretion
following
(Asp- C) aspartame or ( C) aspartic acid administration was similar in
both rates and amounts of excretion. This suggests that the ingested
aspartame rapidly produced free aspartic acid. Also, equal amounts of
14
C from each aspartic acid source (dietary and aspartame] were incorpor-
ated into plasma proteins. The percentage of aspartic acid not excreted
as CO, (='30%) was converted to body constituents via the one-carbon meta-
bolic pool.
Aspartate is also a vital substrate in the urea cycle, as the nitro-
gen atoms in urea originate from ammonium ions and aspartate (6) (Fig. 4}
.
The ammonium ions are converted to carbamyl phosphate, which in turn con-
denses with ornithine to form citrulline. Aspartate condenses with the
citrulline produced to yield argionsuccinate, which leads to the formation
of arginine. The nitrogen originally present in aspartate is contained
in the arginine, while the carbon skeleton remaining from aspartate is
contained in fumarate. The nitrogen is finally transferred to yield urea
when arginine is cleaved by arginase. Fumarate is converted to malate and
oxaloacetate (OAA) , which, upon transamination, yields aspartate, thus
enabling repetition of the entire cycle. Because of the importance of
aspartate to both the Krebs cycle and the urea cycle, it is a major amino
acid in the mitochondria. Along with glutamate, it comprises approximately
50-70% of the total free amino acids found in the mitochondria (7).
Absorption of aspartate in the intestinal lumen depends upon its form
when ingested. When ingested as a free amino acid in the diet, it is ab-
sorbed from the lumen by active transport. When ingested in protein or
peptide form, the peptide enters the mucosal cells where it is hydrolyzed
by specific intracellular hydrolases. Since aspartic acid in the form of
aspartame is ingested as a dipeptide, absorption of aspartate as a protein
or peptide will be the focus of this discussion.
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Studies performed thus far suggest that peptide absorption may be
the major route of protein absorption and that intestinal transport of
amino acids from many dipeptides and tripeptides proceeds at a more rapid
rate than from the equivalent amino acid mixtures (8, 9, 10, 11). That
transport, in several mammals, including man, involves peptides composed
of neutral, basic, and acidic amino acids. Matthews et al . (12) demon-
strated that when a peptide is taken up, competition for transport between
the amino acid components may be partially or completely avoided.
Nixon and Mauer (13), found that only the neutral amino acids and
the dibasic amino acids (arginine and lysine) are quantitatively absorbed
as amino acids. The imino acids (proline and hydroxyproline)
,
glycine,
and the dicarboxylic amino acids (glutamate and aspartate) , all enter
the intestinal mucosa as components of small peptides, where hydrolysis
by specific intracellular peptidases can occur (14).
Gray and Cooper (15) reviewed the major mechanisms by which small
peptides and amino acids are accommodated by the intestinal cell. As-
partate, present as a dicarboxylic peptide, was shown to be absorbed in-
tact across the brush border and then hydrolyzed to its constituent amino
acids by acidic peptidases once inside the mucosal cell. The resulting
glutamate and aspartate free amino acids were then released to the portal
circulation.
Although the majority of glutamate and aspartate peptides in protein
are absorbed intact, specific transport sites for free glutamate and asp-
artate also exist in the gut, with maximal transport observed in the term-
inal ileum (16). Whether originating from protein hydrolysis or from in-
gestion as a free amino acid, aspartate is absorbed from the intestinal
lumen by active transport which is at least partially dependent on sodium
ions (17).
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Phenylalanine Metabolism . The utilization and fate of dietary
phenylalanine is illustrated in Fig. 5. Some phenylalanine present in the
diet passes into the mucosal cell in the free form, leaving the remainder
to be absorbed by the mucosal cell as small peptides, and then broken
down into free amino acids CIS).
Aspartame is a dicarboxylic peptide due to the presence of aspar-
tic acid in its structure. As Gray and Cooper demonstrated (19), dicar-
boxylic peptides are absorbed intact across the brush border and then
hydrolyzed to the constituent amino acids by acidic peptidases once in-
side the mucosal cell. Thus, phenylalanine in the form of aspartame
would be absorbed as a dicarboxylic peptide rather than as a free amino
acid.
After aspartame is hydrolyzed and phenylalanine is available in its
free form, the absorbed phenylalanine passes to the liver and is utilized
for protein synthesis in all tissues to which it is distributed by the
systemic blood. Degradation in the liver occurs via hydroxylation of
phenylalanine to tyrosine by phenylalanine-4-hydroxylase, which requires
a pterin cofactor for completion (20). The tyrosine formed yields hydroxy-
phenyl -pyruvate, resulting in the formation of homogentisic acid and
eventually, the production of CO^.
,
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A minor pathway of phenylalanine catabolism in normal subjects is
represented by phenylalanine transamination to phenylpyruvate. Phenyl-
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acetate, a product of phenylpyruvate, is not further metabolized in
mammals and is excreted in small amounts in the urine (21, 22). This
is the main pathway for phenylalanine degradation in phenylketonurics,
who lack phenylalanine hydroxylase.
14
Ranney et al. (6) also showed that CO, excretion was the same for
14 14
animals treated with ( C) aspartame as for those given ( C) phenyl-
14 14
alanine. Disappearance of radioactivity of Phe- C aspartame and C
phenylalanine in plasma after 48 hours was slow. This suggested that
the phenylalanine was incorporated into a metabolic pool with a slow
turnover time, resulting in the incorporation of phenylalanine into plasma
proteins and other normal body components. Approximately 20% of the
phenylalanine was excreted as CO,, urine or feces, thus leaving the re-
maining 80% to be incorporated into other body constituents. Because
the major fraction of the phenylalanine was being retained by the body,
Ranney et al. performed a second study (23) to determine if continued as-
partame ingestion affected phenylalanine metabolism. After doses of 15
or 60 mg/kg were administered for ten days, it was found that disappearance
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of intravenously administered C phenylalanine from the plasma was un-
affected. The formation of tyrosine from labeled phenylalanine also was
not affected. There was no effect on the rate of CO, conversion and in-
corporation into protein as well, which led to the conclusion that those
doses of aspartame had not altered phenylalanine metabolism. The doses
selected were chosen with extrapolation to humans in mind.
Methanol Metabolism
. Absorption and metabolism of methanol from a
methyl ester such as aspartame may differ from that of free methanol.
Oppermann et al. (24) and Ranney et al. (25) compared the metabolism of
methyl-labeled aspartame and radioactively labeled methanol in rats and
13
monkeys. Equivalent conversion of labeled methyl groups to C0
2
was ob-
14 ...
served with both compounds. However, less CO- was expired during the
first hour after aspartame administration than after methanol treatment.
14
The decreased CO, expiration in the aspartame group may be explained
by the more rapid absorption of methanol from the stomach, the absorp-
tion of aspartame-derived methanol being slowed due to the necessary
passage of aspartame into the small intestine before hydrolysis can occur
to yield methanol.
« m .. intestinal esterases , _, ,.„„„Asp - Phe - Me Asp - Phe + MeOH
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Effect of Aspartame on Plasma Amino Acid Levels . In general, as-
partame loading has been shown to have negligible effects on plasma amino
acid levels. Stegink et al. (26) measured plasma amino acid levels of
both normal and heterozygous phenylketonuric subjects after aspartame
was administered (34 mg/kg) in orange juice. In both groups of subjects,
plasma phenylalanine values (mean + SD) increased from fasting levels
(5.66 + 1.21 umoles/100 ml) to levels normally observed in the postprandial
range (11.11 + 2.49 umoles/100 ml), returning to baseline within 8 hours.
In heterozygous subjects, mean peak levels of phenylalanine were higher
(16.03 + 2.25 umoles/100 ml). Maximum plasma levels, however, were not
significantly above values noted postprandially, which indicated that
aspartame-derived phenylalanine metabolism is slightly slower, yet ade-
quately achieved, by the phenylketonuric heterozygote.
A significant increase in portal plasma glutamate and aspartate
levels is possible by ingestion of large quantities of those amino
acids (27) . The increase in portal levels is proportional to the quant-
14
ity ingested, although some of the ingested dicarboxylic amino acid
nitrogen will be converted to alanine.
Elevations in portal plasma glutamate and aspartate levels do not
necessarily lead to an increase in peripheral plasma levels. The amino
acid composition released to the peripheral circulation is controlled
by the liver because the portal vein first carries blood to the liver.
Stegink et al. (28) observed that the elevation of portal plasma glu-
tamate and aspartate levels caused a significant uptake of those amino
acids by the liver, a large portion of their carbon skeletons being re-
leased to the peripheral circulation as glucose and lactate.
Stegink et al. (29) also demonstrated the liver's ability to reg-
ulate plasma amino acid levels by measuring plasma amino acid levels in
the neonatal pig after glutamate loading in water. At loads of 10 mg/kg
body weight, no increase in peripheral plasma glutamate levels was evident
while slight elevation occurred at a load of 100 mg/kg body weight. The
only major increases were observed when the load was increased to 1 g/kg
body weight.
Metabolism of dicarboxylic amino acids may differ in various species.
Boaz et al. (30) indicated that in the neonatal rodent a different pattern
of metabolites is released to the peripheral circulation after glutamate
or aspartate loading in comparison to that in the primate. In the primate,
the major metabolites released were glucose and lactate, while in the
rodent, additional compounds were observed (a-KG when glutamate was ad-
ministered, and OAA when aspartate was administered) . This may be impor-
tant when considering the susceptibility of the rodent to dicarboxylic
amino acid-induced neuronal necrosis, in contrast to the primate, which
is unaffected.
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Plasma levels of amino acids after administration of aspartame
(34 mg/kg body weight) in both normal and PKU heterozygous subjects were
studied by Stegink et al. (31). No significant changes in plasma aspar-
tate, asparagine, or glutamine levels were observed in either group,
whereas a small rise in glutamate levels was noted in all subjects given
aspartame. However, those levels remained within normal fasting levels
and the increase in plasma glutamate was statistically insignificant.
Plasma phenylalanine levels rose significantly after aspartame
loading in both groups of subjects (31), although levels were considerably
higher in the PKU heterozygotes due to the decreased level of phenyl-
alanine hydroxylase in the PKU liver. Maximal phenylalanine levels for
normal subjects fell in the normal postprandial range for orally-fed
human subjects. Maximal levels for PKU heterozygotes were slightly
higher than normal postprandial values.
A small yet significant increase in plasma tyrosine levels occurred
after aspartame loading in normal subjects at 30 minutes, with no sig-
nificant rise observed in the plasma of heterozygotes (31) . Levels were
significantly higher in normal subjects than in PKU heterozygotes thirty
to forty-five minutes after loading. Those differences were insignifi-
cant at 60 minutes.
Plasma levels of alanine and proline increased significantly in
both groups (31). A response similar to this was observed in subjects re-
ceiving lactose in orange juice (32). Therefore, the increased levels
of alanine and proline could not have been due to aspartame or aspartate,
but most likely resulted from the orange juice or the stress of blood
sampling (33).
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Plasma levels of valine, isoleucine, and leucine decreased signi-
ficantly 90 to 120 minutes after aspartame loading in both groups (31).
This response was probably due to the carbohydrate content of the orange
juice administered (34). Plasma levels of all other amino acids re-
mained virtually unchanged from baseline levels after aspartame load-
ing (31).
Toxicity
.
Questions concerning the safety of aspartame have arisen
due to the possibility of toxic effects of the constituent amino acids,
aspartate and phenylalanine (35, 36). These amino acids, like all chem-
ical substances, may be toxic at very high dosages. From studies done
thus far, however, it is evident that toxicity occurs only under con-
ditions where blood levels of aspartate and phenylalanine are grossly
elevated (in normal subjects).
Stegink et al. (26) observed effects of aspartame loading upon plasma
amino acid levels in PKU heterozygotes and normal subjects. Plasma as-
partate levels were unchanged after administration of 34 mg/kg aspartame
in normal subjects and PKU heterozygotes, which indicated rapid metab-
olism of the aspartate present in aspartame. It is therefore unlikely
that the aspartate content of aspartame administered at that dose poses
any threat of toxicity to either normal persons or PKU heterozygotes.
Plasma phenylalanine levels did increase after aspartame loading in
both normal and PKU subjects. Maximal phenylalanine levels for normal
subjects however, were in the normal postprandial range for orally-fed
human subjects. Maximal phenylalanine levels in PKU heterozygotes
(16.03 +_2.2S ymoles/100 ml) were slightly above the normal range. The
developing homozygous infant appears to tolerate continued exposure to
17
levels higher than this range, so it appears that little risk, if any,
is involved (37). That conclusion seems especially reasonable when the
load of aspartame which was administered is considered. The 34 mg/kg
dose of aspartame administered was estimated to represent the 99.9th
percentile of ingestion when aspartame sweetness replaced all dietary
sucrose sweetness (38). That margin of safety should prevent toxicity
from aspartame consumption, even in PKU heterozygotes.
Administration of large doses of glutamate and aspartate has pro-
duced neuronal necrosis in infant mice (39, 40). Plasma glutamate and
aspartate must be enormously elevated, however, before any lesions are
observed. Plasma levels must reach 60 to 70 umoles/100 ml before the
first sign of neuronal necrosis begins. Therefore, even the acutely
sensitive mouse is able to withstand plasma levels of up to five times
normal aspartate and glutamate levels.
In comparison, plasma glutamate plus aspartate levels up to 500
umoles/100 ml did not cause neuronal necrosis in the infant primate (41).
Neuronal damage or toxicity resulting from dicarboxylic amino acid in-
gestion therefore requires two factors: 1) a sensitive animal species
(rodent) and 2) markedly elevated plasma glutamate and aspartate levels.
The aspartame dose studied did not significantly increase plasma gluta-
mate and aspartate levels, and thus, this dose (34 mg/kg body weight)
should present no risk of toxicity to man.
Uptake by Body Organs .
Liver . The liver is the primary site of utilization for both
aspartic acid and phenylalanine (table 1). The availability of amino
acids to the liver is increased by raising portal venous concentrations
of amino acids, or by accelerating amino acid transport into hepatic
is
Table 1. Classification of the amino acids
Transport system and affinity
utilization
Class
Primary site, of
Basic
Lysine Basic L
Arginine ^
Neutral
Leucine 4 1 M,B
Isoleucine 4 1 M » B
Valine 4 1 M,B
Phenylalanine 4 1 L
Tyrosine 2 2 L
Methionine 4 4 L
Tryptophan 2 2 L
Histidine 2 2 L
Threonine 2 3 L
Alanine 13 L
Serine 13 L
Cystein - L
Proline 3 L
Glycine +/- 2 L,K
Asparagine - L
Glutamine 2 2 G,K
Acidic
Aspartic acid Ac±dic
L
Glutamic acid L ."
a
The amino acids are generally transported by four separate carriers: the
basic, acidic, and two neutral transport systems, the leucine-pref erring
(L) and the alanine-pref erring (A) systems. The relative affinity (from
to +4) of the L and A systems for the respective amino acids is listed
according to Christensen (45).
The primary sites of amino acid metabolism are based on net uptake (ar-
teriovenous differences) data in the 16- to 24-hr fasted organism (46, 47,
48, 49). L, liver. G, gut. M, muscle. K, kidney. B, brain.
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cells. Fasting, for example, has a stimulatory effect on hepatic amino
acid transport (42). Thus, fasting would enhance liver uptake of as-
partic acid and phenylalanine. The insulin antagonists, epinephrine,
glucagon and growth hormone, are the probable mediators of this effect,
whereas infusions of glucose and insulin inhibit splanchnic (hepatic)
clearance of amino acids (43). Tews et al . (44) showed that high pro-
tein diets also apparently increase liver capacity to transport amino
acids, an increase attributed to the effects of glucagon.
Competition among similar amino acids (e.g., neutral) at physiolo-
gical levels is insignificant in the liver. For example, if the per-
fused liver is exposed to 15 mM valine, (approximately 100 times the
usual plasma concentration), the intracellular valine concentration in
the liver approaches 15 mM. The concentration of other large neutral
amino acids in liver remains unaltered, however (50). Concentrations of
individual amino acids as high as 60 mM are necessary to inhibit the
transport of neutral amino acids (for example) such as phenylalanine (51).
All data thus suggests that aspartame ingestion would not inhibit amino
acid transport in the liver.
Brain and Blood-brain Barrier
.
The association of hyperphenylalan-
inemia with mental retardation in PKU subjects has caused concern about
the relationship between plasma levels of free amino acids and brain
function. Uptake of free amino acids into the brain is dependent upon
the same interactions between carrier mechanisms observed in other
tissues (52, 53). One transport class includes the branched-chain and
the aromatic amino acids (54). As a consequence of this common transport
system, plasma levels of tyrosine, tryptophan, and the branched-chain
20
amino acids will influence entry of phenylalanine, and likewise a high
level of phenylalanine will result in a depressed uptake of these other
amino acids. Peng et al
. (55) added 5% L-phenylalanine to the diet of
the rat, which resulted in a seven- and eight-fold elevation of plasma
phenylalanine and tyrosine levels, and a four-fold elevation in brain
levels. The brain concentrations of leucine, isoleucine, valine, methio-
nine and histidine, which occurred simultaneously, were severely depressed.
This depression took place without a corresponding reduction in blood
plasma levels and therefore suggested competition by phenylalanine and
tyrosine for the transport carrier into the brain.
Great excesses of amino acids in the diet can alter the brain free
amino acid pattern and thus protein synthesis. One good example of
this effect was demonstrated by work with phenylalanine (56). Single
doses of 1 g/kg phenylalanine were intraperitoneally injected into the
brain of a 7-day-old rat, resulting in an increase of brain phenylalanine
and a depletion of brain tryptophan. Inhibition of protein synthesis
occurred and was correlated with the tryptophan depletion but not the
phenylalanine increase, suggesting that the altered protein synthesis
was due to lack of tryptophan. Synthesis returned to normal levels when
injections of phenylalanine and tryptophan were given simultaneously.
Many studies have shown that excessive doses of other amino acids
also decrease protein synthesis in the brain (57). Doses such as these
do not necessarily affect brain protein synthesis by limiting uptake and
availability of other amino acids. Two amino acids, L-dihydroxyphenyl-
alanine (dopa) and L-5-hydroxytryptophan (5-HT) (58-60) cause disaggre-
gation of whole brain polysomes by producing their respective neuro-
transmitter products, dopamine and serotonin. A reduction in the brain
protein synthesis rate accompanies the disaggregation (61) . In both
21
cases, the amino acid precursors (phenylalanine and tryptophan) do not
inhibit protein synthesis via direct action of the amino acids them-
selves or from an amino acid imbalance; the polysome changes take place
only after dopamine or serotonin synthesis has been completed.
As Table 1 shows, phenylalanine, as a large neutral (essential)
amino acid, is preferentially transported by the L-system, which is
sodium independent and does not concentrate amino acids within the
cell (62). A study of phenylalanine transport in rat cerebral cortex
slices (63), however, indicated a partial sodium dependency. Thus, two
different transport systems for phenylalanine, one sodium-dependent and
the other sodium independent, may exist in the brain.
Both dicarboxylic amino acids are thought to serve as neurotrans-
mitters in the central nervous system. Considerable evidence suggests
that L-glutamate and L-aspartate function as excitatory transmitters (64)
.
A high affinity uptake system into nerve terminals is the physiological
mechanism by which their neurotransmitter action is terminated (65, 66)
.
Maintenance of adequate rates of neurotransmitters and proteins in
the brain relies on the availability of sufficient amounts of precursor
amino acids. The rates at which amino acids enter neurons are dependent
upon the affinities and capacities of transport systems for these amino
acids in neuronal membranes. Reports that changes in brain tryptophan,
tyrosine, and phenylalanine pools alter the synthesis of proteins and
neurotransmitters led to a study by Archer and colleagues (67). Amino
acid transport was studied in three neuroblastoma clones: N-TD6, which
synthesizes norepinephrine; N-T16, which synthesizes small amounts of
serotonin; and N-S20Y, which synthesizes acetylcholine. Tyrosine, phenyl-
alanine and tryptophan enter all three clones by rapidly exchanging trans-
port systems. Results of this study suggested that if similar amino acid
transport systems exist in neuronal membranes and if amino acid levels in
brain extracellular fluid are similar to levels in plasma, such systems
may serve to limit the entry of amino acids into brain cells when blood
amino acid levels are near the normal physiological range. Those results
thus lead to the conclusion that amino acid pools in the brain are con-
trolled by neuronal amino acid transport systems and are therefore limit-
ed so that neurotransmitter synthesis is not altered.
Muscle . Degradation of amino acids in the muscle is mainly limited
to the branched chain amino acids (68). Other amino acids, including
aspartate and phenylalanine, are taken up and degraded in relatively
small amounts by the muscle. However, the supply of those amino acids
to muscle may be enhanced by adaptive increases in transport as well as
by increases in plasma amino acid levels. (Such increases may occur as
adaptations to exercise and will be discussed separately in a later
section)
.
Studies of amino acid exchange across muscle tissue of the human
forearm have revealed that in the postabsorptive state, there is a net
release of amino acids from muscle (69-71). The output of alanine and
glutamine was greater than that for all other amino acids and was respon-
sible for over 50% of total alpha amino nitrogen release (72).
Net uptake during rest consists of small but consistent uptakes of
serine, cystine, and glutamate (73-75). Aspartic acid is taken up by
resting muscle also, but in comparatively insignificant amounts, as
Ahlborg et al. (76) demonstrated. Phenylalanine was shown to have a net
release from resting muscle, although the amounts released were also
found to be relatively small (table 2, next section).
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Competition between neutral and aromatic amino acids (e.g. phenyl-
alanine) for uptake is not a problem in muscle. Guoff et al . (77) dem-
onstrated that fact by a study in which pharmacological doses of aromatic
amino acids markedly inhibited the brain uptake of other neutral amino
acids yet failed to affect muscle amino acid levels. Christensen and
Cullen (78) showed that large intraperitoneal doses (1000 mg/kg) of AIB
(the nonmetabolizable amino acid ct-aminoisobutyric acid) raised plasma
AIB levels to 15 mM yet exerted no competitive effects on muscle uptake
of other circulating amino acids.
In general, studies on muscle amino acid transport provided evidence
which indicated that phenylalanine transport as well as that of other
neutral amino acids is unaffected by the presence of other amino acids.
All evidence gathered thus far suggests that at physiological plasma amino
acid levels, competition for muscle transport sites does not occur.
Hormone Interactions
Insulin . Amino acid metabolism and, consequently, plasma amino
acid levels, are affected by hormones, the most pronounced effect being
exerted by insulin (79). Deposition of plasma amino acids in muscle
due to insulin secretion can be stimulated by carbohydrate in the diet.
This effect results in a depression of plasma levels of many amino acids,
especially the branched-chain amino acids, (valine, leucine, isoleucine),
phenylalanine and methionine (80-83). Therefore, free amino acid levels
in the blood after a meal are dependent upon the quantity of ingested
amino acids removed by the liver and upon the amount deposited in the
peripheral tissues, notably in muscle, as a result of the action of in-
sulin. In addition to its effect in decreasing the concentration of
circulating amino acids, insulin also influences interorgan exchange of
amino acids and is related to gluconeogenesis as well.
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Felig (84) demonstrated that insulin lowered the concentrations
of amino acids effectively in eviscerated animals, which suggested
that
muscle tissue was the site of insulin-mediated amino acid uptake.
Lot-
spetch (85) showed that dogs responded to insulin by a similar
lowering
of individual amino acids which corresponded to their relative
concentra-
tions in muscle protein. Studies in the human forearm have
demonstrated
that the insulin effect of decreasing plasma amino acid levels is
due to
a net inhibition of amino acid output from muscle (86). A reduction
in
net output was observed for leucine, isoleucine, methionine, tyrosine,
phenylalanine, and threonine. A net uptake of glutamate was demonstra-
ted (87).
Contrary to the effect noted in other amino acids, insulin secre-
tion causes a rise in arterial alanine levels in normal man (88). In-
sulin effects on lowering alanine plasma levels or inhibiting muscle
output of alanine have been absent. In isolated diaphragm, insulin has
led to an increased alanine output from muscle while leading to a de-
crease in the release of all other amino acids (89). This behavior
can be attributed to insulin-stimulated synthesis of alanine from glu-
cose-derived pyruvate, as proposed in the glucose-alanine cycle (90).
Insulin also exerts its influence on amino acid metabolism via its
role in the regulation of gluconeogenesis. Not only does insulin in-
crease glucose utilization by fat and muscle, but it also inhibits glu-
cose release from the liver (91). Direct evidence of this effect was
14
provided by a study demonstrating insulin inhibition of C-alanine
incorporation into glucose in the perfused liver (92).
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Glucagon . Pharmacologic doses of glucagon exert a hypoamino-
acidemic effect on virtually all amino acids (93-95). In contrast to
the effects imposed by insulin, alanine is the amino acid most affected
by glucagon, and it shows the greatest decline in plasma levels (96).
Increased uptake by the liver has been observed to be responsible for
that effect (97). In the perfused liver, glucagon enhances the con-
version of alanine to glucose (98) and stimulates intracellular trans-
port and utilization of glycogenic amino acids (99), also an effect
most pronounced in alanine.
In muscle, glucagon increases branched chain amino acid oxida-
tion (100), decreases protein synthesis from amino acids (101), and
increases muscle amino acid output (102). In general, glucagon exhi-
bits a catabolic effect on amino acid metabolism in which the transfer
of amino acids from muscle to liver for conversion to glucose occurs.
Amino Acids as Secretagogues . Hormone-amino acid interactions
not only include the effects of hormones on amino acid metabolism, but
also the reverse effects — amino acid stimulation of hormone secretion.
Protein ingestion may in fact be the most important physiologic stimulus
for glucagon secretion, a major factor in the prevention of hypoglycemia
which otherwise would accompany the insulin increase after a protein
meal (103).
Aspartic acid and phenylalanine are major glucagon secretogogues
as well as strong insulin 8-cell secretogogues (104, 105). Studies thus
far, however, have indicated that aspartate or phenylalanine ingested
in the form of aspartame do not stimulate either glucagon or insulin
secretion (106, 107).
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III . Aspartame and Exercise
In considering the total population of weight-conscious Ameri-
cans, an increasing number of this total are utilizing exercise as a
method of weight control . Although no formal statistics have been ac-
cumulated, it is reasonable to assume that many of these "exercisers"
also incorporate the use of the low calorie sweetener aspartame (4 kcal/
gram) in their diets as an added measure of weight control. It is
therefore important to determine the physiological effects of inter-
action between aspartame and exercise.
Since studies on this specific interaction are virtually nonexist-
ent, protein metabolism in exercise will be focused upon. Any specific
effects of aspartame or its component amino acids will be noted.
Composition of Muscle . Muscle tissue accounts for approximately
40% of total body weight, representing the largest source of protein
in the body (108). The most predominant type of muscle, the skeletal
or striated muscle, is that which is directly responsible for per-
forming work during exercise. Skeletal muscle is composed of 75% water,
20% protein, and S% inorganic salts and other substances. The most a-
bundant muscular proteins are myosin, actin and tropomyosin, comprising
about 52%, 23% and 15%, respectively of the total protein content of
muscle. Also, the conjugated protein myoglobin is incorporated into
muscle tissue (700 mg Mb/100 g muscle tissue) (109).
Due to the contribution of protein to muscle composition, it is
evident that protein is important in the structure and function of
muscle. But how important is protein as an energy source? Does pro-
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tein supply a significant amount of fuel during exercise? These are
questions that must be considered in determining the effects of inter-
action between aspartame and exercise.
Protein Metabolism and Exercise . Energy for muscle contraction
is derived through hydrolysis of the high-energy phosphate bonds from
either adenosine triphosphate (ATP) or creatine phosphate. Due to the
small concentration of these substances in muscle, a continual regen-
eration of the high energy bonds must occur if exercise is to proceed
for an extended length of time. The role of skeletal muscle in ex-
ercise is to regenerate ATP from anaerobic and oxidative metabolism
of carbohydrate and fat. Together, these two fuels provide approxim-
ately 90% of the energy required for exercise (110, 111). Thus, the
contribution of protein to the fuel supply used during exercise is
relatively minor in comparison to that of carbohydrate and fat. How-
ever, current research has revealed that amino acids can contribute to
whole body metabolism, providing up to 5.5% of the total caloric cost
of exercise, as estimated by Evans et al. (112). Two major approaches
in the determination of the amount of protein used as fuel during ex-
ercise are 1) nitrogen excretion studies and 2) amino acid oxidation
studies. Results of those studies will help clarify the role of pro-
tein as an energy source.
Nitrogen Excretion Studies . Decombaz (113) measured urinary urea
clearance in 11 trained runners after completing a 100 km race, re-
cording a net decrease in rates of urea clearance during the race and
a net increase during the 24-hr period following. Plasma urea levels
were 50% higher after the run, remaining elevated for 24 hours. The
rise in plasma urea accounted for only a portion of the decline in urea
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clearance rates; urea production rates averaged 44% higher during the
race in comparison to pre-race rates. In a similar study (114), neither
a decline in urea clearance during a 2 hour bicycle ergometer ride or
during a 70 km ski race could explain the rise in plasma urea.
Those studies show that continuous moderate to heavy exercise
increases urea production and decreases urea clearance that is approx-
imately balanced by an increased elimination of urea through sweat.
Based on those results, Lemon and Mull in (115) estimated that up to 12%
of the energy cost of exercise may be contributed by protein.
Amino Acid Oxidation Studies . The second method used to determine
the amount of protein used as fuel during exercise is the measurement of
the oxidation of amino acids. Until recently, the liver was believed to
be the major location of amino acid degradation in mammals (116). How-
ever, several studies have now proven that non-hepatic tissues, espec-
ially skeletal muscle, can oxidize amino acids, the branched chain amino
acids (BCAA) being preferred (117-119). Khatra et al . (120) showed that
60% of the total body distribution of the enzymes necessary for BCAA
catabolism (BC a-keto acid dehydrogenases) are located in skeletal muscle.
Another study (121) demonstrated that the oxidation of alanine, glutamate,
and leucine may contribute up to 20% of the total CO-, produced when iso-
lated muscle is supplied with a medium of 18 amino acids (and no other
substrates). The oxidation of valine, isoleucine, and aspartate also has
been reported (122) in skeletal muscle. Dohm et al . (123) found that
leucine oxication increased with endurance training, suggesting that
enzymes involved in muscle leucine oxidation may undergo an adaptation
to training similar to that observed in carbohydrate and fat catabolism
enzymes.
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Some variation in BCAA oxidation occurs among species, as the total
BC oc-keto acid dehydrogenases in rat muscle is significantly less than
that in man. (10% in rat; 60% in man) (124) Therefore, BCAA oxidation
in human skeletal muscle is much more likely than in the rat. The studies
cited above were performed on rats, but it is possible that amino acid
oxidation in man makes a significantly larger contribution to exercise.
The Glucose-Alanine Cycle . Felig et al. (125) observed an increased
alanine output from exercising skeletal muscle and in another study (126)
demonstrated that this rise in alanine output is proportional to the in-
tensity of exercise. Those results suggested that amino acids in muscle
are transaminated to form alanine from glucose-derived pyruvate (Fig. 6).
The source of the amino groups for the formation of alanine may be the
BCAA within skeletal muscle (127) . That theory was supported by the ob-
servation that alanine released from exercising muscle increased when
leucine was available via the bathing medium.
Another important factor is the release of liver BCAA into the
blood, unlike other amino acids which can be utilized for gluconeo-
genesis. That effect suggested that the liver also may provide BCAA to
skeletal muscle (128) . Shunting those amino acids to muscle would supply
an additional source of carbon to be oxidized for energy. Decreased
insulin and increased glucagon during exercise would enhance protein
degradation and thus maximize the supply of BCAA to be oxidized (129)
.
In combination with the enhanced glucose utilization during exercise,
that fact could account for the dramatic increase in alanine output from
working skeletal muscle.
30
LIVER BLCCD MUSCLE
GLUCOSE—» GLUCOSE • ' GLUCOSE .
GLYCOGEN
-GLYCOGEN
UREA PYRUVATE
ALANINE » ALANINE
PYRUVATE
• ALANINE
-NH2
4 LEUCINE 1 r LEUCINE 1 {^** ZSOLEUC1NE\—*\ ISOLEUCINE *"
VALINE VALINE PROTEiN
Fig. 6 The glucose-alanine cycle. Odessey et al. (127).
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Ahlborg et al. (130) determined the net release and uptake of amino
acids in leg muscles before and during exercise. In addition to the
net uptake of BCAA as observed in the previously cited studies, results
of phenylalanine and aspartate exchange also were noted. The exercised
muscle showed a net uptake of both phenylalanine and aspartate, although
not in significant amounts in comparison to the quantity of BCAA taken
up (table 2)
.
Glucoregulatory Hormones and Exercise . Another effect of exer-
cise which may indirectly affect amino acid transport is the stimulation
of increased glucagon to meet increased energy needs of muscle contrac-
tion. Chambers et al. (131) demonstrated that glucagon increased amino
acid uptake by the isolated rat liver when administered in vivo prior
to sacrifice or when added directly to the isolated system. Glucagon
stimulation by exercise also caused increased lipolysis and therefore
an increase in intracellular free fatty acids. Herrera and Renold (132)
suggested that those fatty acids played a role in regulating amino acid
uptake through uncoupling oxidative phosphorylation and thus, in decreas-
ing the supply of energy for active transport. Insulin could release
this inhibitory effect on transport by decreasing lipolysis. The evi-
dence from that study suggested decreased insulin levels due to exer-
cise may inhibit amino acid transport in the muscle. That may be nec-
essary for the increased uptake of most amino acids (including phenyl-
alanine and aspartate) during exercise.
Other studies indicated that the physiologic importance of hormone
changes during exercise relate primarily to stimulation of hepatic glu-
cose production rather than enhancement of glucose utilization (133).
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Arterial concentrations , splanchnic exchange, and leg exchange
of individual neutral and acidic plasma anino acids at rest and
during prolonged exercise. Ahlborg et al. (130).
'I
F..\ercise
Ki-t HI min 240 mitt
Threonine II2±I3 114 ±1.1
<trint 119*11) HI ±18
Proline 172 ± 10 174±l,f
CltfUlliM .16 ±.
1
.10 ±2
Glycine 188±16 206 ±11
U»nine in±22 271±2»1
^Aptfoobutynite 29±,1 26±2
Vjdill'- 242±IJ 2,1S±1I
CjftiM 84 ±15 «±M
Mrtliionmc 17 ±2 19±2
Iwleucine Ml ±4 Oil ±2
Uucme 12o±7 127 ±4
Tyrosine 45 ±4 49 ±5
phenylalanine 44±j 49±j
1. 1) ±1.5
II. 1 ±1.5
6.2±J.O
J.7±2.5
K.5±l).8
8..! ±1.2
DaUare presented as mean±SKM
Rata refer to amino acid ntcluttgf
Significantly different from tlie i:orr
Significantly different irom
'Significantly different from
irnwi Sotli lei;
ipondim valu
n-Mponding value
-1.6*2.5
2.8 ±0.7
[7.9±0.0
22.4 ±.1.2
15.2±2.7jj
-ft.5±1,<)
.U.8±4.(i ,r
I19.0±I8.9*
1.1.8±ll.2
-.1|.6±6.8»
-17.2±2.9*
-30.2±4.7*
in' correspondi al rest, P < H.tli (paired f lent),
lie corresponding vain? at re-t, /' < 0.0115 (pairi'd i test],
1 .4 ±1.0
1 .ft ±1,1)
1.6 ±2.2
5.4±2.0
4.8 ±5.(i
2,(1 ±0.6
2.2 ±4.4
12.2±2 1.0
15.8±22.0
-4.8 ±6.8
7.6 ±15.2
-44.6 ±20.0
.1.4 ±3.8
31,6±I7.0
-2.8±2.6
8.2 ±8.0
li2±10.4
10.2 ±2.4.;
I7.8±17.4
-95.4±*3.6|
5.H±4.4
43.4±15 6|
2.1,6±20,8
-4.0±4.(.
2 1.8 ±4.2*
28,6±7.81
33
Those studies have demonstrated the extreme sensitivity of liver gly-
cogenolysis to the inhibition exerted by insulin, thus stressing the
importance of hypoinsulinemia in regulating hepatic glucose production.
In prolonged or severe exercise, increased glucagon and growth hormone
also contribute to this response. However, neither hypoinsulinemia nor
hyperglucagonemia have been proven necessary for exercise-induced stim-
ulation of liver glucose output (134) .
Effects of Aspartame During Weight Reduction . Because a potent
sweetener of little caloric value such as aspartame is very likely to
be used by weight -conscious persons, Knopp et al . (135) decided to de-
termine the potential for aspartame toxicity during weight reduction.
The possibility of long-term effects of aspartame on the fuel hormonal
alterations characteristic of calorie restriction were the focus in
their study. Fig. 7 illustrates the changes in plasma immunoreactive
insulin (IRI) and glucagon (IRG) as well as the extent of the weight
reduction and glucose reduction which occurred in both aspartame and
placebo groups. In general, the results suggested that weight reduc-
tion in the subjects studied caused a detectable shift in metabolism,
while simultaneous administration of aspartame did not result in a sig-
nificant effect. The changes in IRI and IRG at week 7 were due to the
decreased food intake and the increased dependence on endogenous fuels
for energy and the need for enhanced gluconeogenesis to meet the needs
of the brain and other tissues, such as muscle (136).
Although shifts in glucose, insulin and glucagon normally accompany
caloric restriction (137), the study by Knopp et al . (135) indicated that
aspartame produced no significant effects during weight reduction. Be-
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cause both aspartic acid and phenylalanine, as mentioned previously,
are potent glucagon secretogogues, it is important that those partic-
ular amino acids ingested in the form of aspartame do not exhibit
synergistic effects with another glucagon stimulus such as calorie
restriction. If ingestion of aspartame shows a similar non-stimulatory
effect on glucagon in future studies involving weight reduction, it
may be reasonable to conclude that aspartame ingestion might likewise
have no detectable effects on exercise, since the response of gluco-
regulatory hormones during exercise is similar to that observed in
calorie restriction.
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MATERIALS AND METHODS
Animals and Their Care
The experimental animals were 3 week-old male Wistar rats (HSD:
WI:BR, Harlan Sprague Dawley, Indianapolis, IN) weighing 60-85 g.
Animals were housed individually in stainless steel, wire bottom cages
(18 x 24 x 18 cm) and received water ad libitum throughout the nine-
week study. Room conditions were maintained at 22 C with an automatic
12-h light-dark cycle.
The experimental design was a 2 x 2 factorial where the main treat-
ment effects were aspartame supplementation and exercise. The control
diet (Table 2) was Teklad TD 83448 Purified Diet with 65% cornstarch
(Teklad Test Diets, Madison, WI) . The aspartame-supplemented diet was
formulated by substituting 0.6% aspartame for 0.6% cornstarch. Diets
were isocaloric. Rats in exercise groups were exercised 75 min/day,
2
5 days/wk (Mon-Fri) , on a motor-driven zero-grade treadmill in the late
morning hours. The initial two weeks of the nine-week study were the
"training" period in which the animals were gradually adapted to a target
speed of 24 meters per minute (Table 3) . This speed was maintained for
the remaining seven weeks of the study.
Rats were weighed twice a week (Mon. and Sat.) and feed intake was
measured daily throughout the nine-week period. Weekday weight gain was
calculated by subtracting Monday body weight from Saturday body weight.
Weekend weight gain was calculated by subtracting the previous Saturday
body weight from the Monday body weight. Daily feed intake for each rat
was derived by subtracting amount of feed left or spilled each day from
weight of feed administered on the previous day.
The aspartame was generously supplied by the Searle Company (Skokie, 111.)
Correspondence is in appendix tables 1 and 2.
2
Radiotrol Treadmill, h h.p. , Boston Gears, Quincy, MA.
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TABLE 2
Experimental diets
Control
Aspartame
Sup plemented
Casein, high protein 20.0 20.0
DL-Methionine 0.3 0.3
Corn Starch 65.0 64.4
Corn Oil 5.0 5.0
Fiber (cellulose) 5.0 5.0
Mineral Mix, AIN-76 3.5 3.5
Vitamin Mix, AIN-76A 1.0 1.0
Choline Bitartrate 0.2 0.2
Ethoxyquin (antioxidant) .001 .001
Aspartame 0.0 0.6
''Teklad TD 83448, Purified Diet with 85% Corn Starch. This diet is
similar to AIN-76A except that sucrose is substituted by cornstarch.
Teklad TD 85033, Basal Mix (Adjusted Corn Starch). This basal mix
was designed to be used at the rate of 994.0 g/kg of diet, in con-
junction with 6.0 g/kg aspartame.
38
TABLE 3
Initial two-week training period for rats
Treadmill Meters per
dial minute
Mon.
Tues.
Wed.
Thurs.
Fri.
Mon.
Tues.
Wed.
Thurs.
Fri.
25 6
35 10
40 12
45 14
50 16
55 - 60 18
60 - 65 20
65 - 68 22
70 24
72 24
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Sacrifice Procedures
At the end of the nine-week study the rats were fasted 12-16 h
before being sacrificed by exsanquination through heart puncture. A
dehairing mixture used previously by Crews et al. (138) was then applied
to remove the rat fur. The mixture was composed of barium sulfide
(200 g) , Tide detergent (50 g) , and 10% glycerol (500 ml mixture)
.
After washing the rats, the gastrointestinal tract from the gas-
troesophageal sphincter to the anus was removed from each rat. This
measure was followed to minimize variations in body weight caused by
periodic feeding behavior of the rats. The lungs also were removed to
permit accurate hydrostatic (underwater) weighing. Heads and tails
were removed using an electric knife. Each carcass was then blotted
with paper towels (inside and out) and weighed on a Toledo dual-pan
balance. This weight, for later reference, is considered "carcass weight
in air."
Each carcass (whole rat minus hair, gastrointestinal tract, head and
tail) was then weighed underwater. The hydrostatic weighing apparatus
utilized was a simple set-up constructed as follows. A trip balance
(Cent-o-gram Model 311, Ohaus) was positioned above a cylindrical glass
container (22 cm diam. , 31 cm ht.). The weighing pan of the scale was
replaced with a commercial wire-mesh vegetable basket (Walmart) which was
large enough for a rat carcass but small enough to fit inside the glass
cylinder. The wire-mesh basket was weighted with ordinary fishing sinkers
to provide additional gravity, but an no time during the weighing proce-
dure was the basket allowed to touch the side or bottom of the glass con-
tainer. The weight of the basket alone was recorded prior to weighing
each carcass. Water temperature also was noted for each weighing to cal-
4culate the K value for the Specific Gravity equation later described.
Appendix Table 3 shows the relationship between temperature and water
density.
The carcass was submerged underwater in the basket and rotated to
release any air bubbles trapped in the body cavity, and the skin was then
stroked to remove any additional clinging air bubbles. Weight was re-
corded to the nearest .01 g.
Body specific gravity was calculated using the following formula,
used previously be Dahms and Glass (142) which showed a strong correla-
tion between percent body fat and body specific gravity in rats:
Specific Gravity WA „
(WA - WW)
WA = carcass weight in air
WW = carcass weight in water
K specific gravity of H^O saturated with air
(.997327 @ 24 C)
Percent body fat was then calculated as follows:
% fat = -394. 498 (specific gravity) + 431.35
Upon completion of the hydrostatic weighing procedure, the liver,
kidneys and heart were removed from each carcass and weighed to the near-
est .01 g. The organs were then blotted dry and wrapped individually in
labelled foil wrappers for storage at -18 C.
Next, abdominal, epididymal, and retroperitoneal fat deposits were
removed and weighed to the nearest .1 g. These tissues then were dis-
carded. Finally, four leg muscles were removed from the left hind limb
of each carcass: the gastrocnemius lateralis and medialls as well as
the vastus lateralis and medialis. The vastus muscles were from the
thigh; the gastroc muscles from the calf. The muscles were weighed to
the nearest .01 g, wrapped, and stored as described for the tissues.
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The blood samples (8-10 ml each) that were taken by cardiac punc-
ture were allowed to clot (30-60 s) and immediately centrifuged at 5000 g
for 8 min to separate the serum. Serum was stored at -18 C until later
analysis.
Analytical Procedures
Serum triglycerides. Serum triglycerides were measured enzymatically
using Fisher Kit No. CS-876 (Fisher Scientific, Fair Lawn, NJ) . In this
procedure triglycerides are hydrolyzed to free fatty acids and glycerol.
The glycerol is converted to dihydroxyacetone phosphate through a series
of steps where NADFL is released and forms formazan. The latter is a
pink color readable at 500 nm.
The first step of the assay procedure was the reconstitution of tri-
glyceride reagent vial (CS-876-A) with 11.0 ml buffer (CS-876-B) . Two ml
aliquots of triglyceride reagent were placed in 12 x 77 ml disposable
tubes and warmed in a 37 C water bath for 5 minutes. At timed 30 s
intervals 20 ul of either saline (blank), standard (200 mg% triolein),
or serum were pipetted into the tubes, mixed, and allowed to incubate 10
min. Usually each run included one blank, one standard and ten samples.
At the end of the 10 min incubation, tubes were removed again at 30-second
intervals and absorbance was read with a Brinkmann PC 800 colorimeter.
The latter instrument had a 545 nm filter which, even though it was not
the 500 nm suggested, previous studies indicated it was suitable for
measuring pink chromophore reactions. Triglyceride contents of each
serum sample were determined by linear regression using the blank and
standard values as reference points.
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Serum cholesterol. Total, HDL, and LDL cholesterol levels were
measured using the LDL-Direct Cholesterol Audit System (Isolab, Akron,
OH) . In this assay total cholesterol was determined by adding serum
directly to the cholesterol reagent; but for HDL and LDL cholesterol the
serum was added to an affinity column, eluted sequentially with Alpha
Agent for Alpha cholesterol, and Beta Agent for HDL cholesterol. The
fractions collected were then added to cholesterol reagent, mixed, and
incubated at 37 C for 15 min. The absorbance of the pink chromophore was
read at 545 nm with a Brinkman PC 800 colorimeter. Specific instructions
on column preparation and procedures are in Appendix Table 4 and are a-
dapted from those given by another investigator (139)
.
Serum glucose . Glucose was determined using Sigma Kit No. 510 (Sig-
ma Diagnostics, St. Louis, MO), which is a quantitative, enzymatic (glu-
cose oxidase) procedure. In this procedure serum is added to a mixture
of glucose oxidase, peroxidase, and o-dianisidine. During incubation
the glucose is converted to gluconic acid and H^O-,. The hydrogen peroxide
then reacts with the o-dianisidine to form oxidized o-dianisidine, a
brown chromophore.
In this procedure the PGO enzymes and o-dianisidine are reconstituted
to form the combined color reagent. Five tenths ml sample (diluted 1:20)
or standard (100 mg/dl diluted 1:20) or water (blank) was added to 5.0 ml
combined color reagent. After mixing tubes were incubated at 37 C for
30 min for the brown color development, samples were read on a Summerson
Klett meter using a green filter. Glucose contents of each serum sample
were determined by linear regression using the blank and standard values
as reference points.
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Tissue lipids . Tissue lipid levels were determined for liver,
kidneys (both pooled), heart, and muscles taken from the left hindlimb
including vastus lateralis, vastus medialis, gastrocnemius lateralis,
and gastrocnemius medialis. The Folch gravimetric method (140) was used
except that the initial extraction mixture was methylene chloride :methanol
(2:1, v/v) as suggested by Chen et al (141) instead of the more hazard-
ous chloroform:methanol mixture used by Folch.
Aluminum dishes (S/P catalog No. D2165) were labeled with a perm-
anent marking pen, dried 1-h in a 103 C forced-air draft oven, cooled at
least 1-h in a desiccator, and weighed to the nearest mg. Dishes were
then arranged in the work area so that pipetting could be performed in an
organized manner.
After the dishes had been prepared, samples weighing 0.5 - 1.5 g were
homogenized in 15 ml methylene chloride :methanol for 30 s using a Poly-
tron high-speed homogenizer (Brinkmann Instruments, Westburg, NY) which
worked well even for the muscle tissues. Homogenates were then filtered,
and collected matter was washed with 5 additional ml methylene chloride:
methanol. Four ml 0.73% NaCl were added and tubes were shaken 5 min on
an automatic shaker. After centrifugation for 5 min the top aqueous layer
was aspirated off and 7.0 ml of the bottom organic layer (containing the
lipids) was pipetted into the aluminum dishes. The solvent was allowed to
evaporate and the dishes were again dried at 103 C for 1 h. After cooling
in a desiccator, dishes containing the lipid residue were weighed to the
nearest mg. Percent fat (lipid) was calculated by multiplying mg lipid
in each dish by 16/7 (because 7.0 ml organic layer was used out of a total
of 16), dividing by weight (in grams), dividing by 1000 (to convert mg to
g) , and multiplying by 100 (to get %)
.
Statistical Analyses .
Two-way analysis of variance procedures were used where the main
treatment effects were exercise and aspartame. The interaction between
exercise and aspartame was also examined. The sources of variation are
shown below:
SOURCE df
Model (3)
Exercise 1
Aspartame 1
Exercise*Aspartame 1
Error 32
Corrected Total 35
Analysis for each dependent variable was accomplished using SAS (Stat-
istical Analysis System) computer language. A copy of the program is
shown in Appendix table 5.
RESULTS
Effects of Aspartame and Exercise on Weight Gain
The effects of aspartame and exercise on weight gain of rats during
the nine week study are presented in Table 4. When total weight gain of
all groups was compared, exercised animals showed a significantly lower
weight gain (P<.01) than the non-exercised groups. When average daily
gain of all groups was compared, the exercised animals again showed a
significantly lower weight gain (P<.01). These effects were attributed
to the lower average weekday gain (M-F) , as no significant differences
among groups were detected in average weekend gain. Aspartame-fed rats
gained a similar amount of weight when compared to those not fed asp-
artame.
Effects of Aspartame and Exercise on Feed Intake
The effects of aspartame and exercise on feed intake during the
nine week study are shown in Table 5. The average daily feed consump-
tion of exercised animals was significantly lower (P<.01) than that of
non-exercised animals, even when expressed per lOOg body weight. No
significant effects on total daily feed intake resulted from aspartame
supplementation. However, when average daily feed consumption per lOOg
body weight was calculated, aspartame supplementation did have signifi-
cant effects on daily feed intake. Both aspartame -supplemented groups
(non-exercised and exercised rats) consumed less feed per lOOg body
weight (P<.0S) than those not fed aspartame.
The lower feed consumption of exercised rats was attributable to
average weekday feed consumption rather than average weekend feed con-
sumption. The exercised animals consumed less feed per weekday (P<.01)
45
46
0)
1
51E
<T3 I
L
03
o
q in
in <c
*- +
U I
L
cd q i
X E
LU fC I
° 51X E I
LU :u
71 +j i
i-HO
O
[_
CO CO CO CO o
z. 2 z z
o
a
co CO co CO
z. IS z. z
c <d
<0 r—
U XI
4- 1-
i—
1
o o o CO
z
C X
ca««-o o o
U) C
<D
•• Q.
CD Q.
U <
C
CN CN CN A3 C
+1 +1 + 1 + 1
CC CM ^~ > *
Lfl O
ro 1X1 LT) r^
O in
en in
U) =3
r—
1
m >>•—
p*. i— (0
+ 1 +1 H +"l <o >
c
o ^o i—
i
en < .—
*T (0
ro LO LO
o
3
• X)
CL-«-
3 >
o *-
L. T3
m CN ^r
i-H r-<
-P
+
1 + 1 + 1 + 1 c5
CN CN CM i-i
m i£) MD t£> ID CD
CD
-P
t- rtJ
+» u
I-
-o
CN CN CD C
Ol Q."-
+ 1 + 1 H +1
m 0)
r- . . <o <a
rn \D vjD (0
O
C- CD
c c O M-
4- »*-
to m
CD D)
LU ,-,
CO CO
Ll_
1
CO z
c ^ CO
in +j
<0 c c
CD >> "O <Q IQ
fO c © O
>•, o CD
.* J£. <«-
E CD CD -^
13 0) CD E- C
<T3 -o a i <o O)
Oi
03 o CD in in
•P CO U) O) CD C
-c rC IU 10 3 O
CT i_ s. u r— C
0) 0> CD (0
0) > > > >• l_S < <c < * O
47
JS
'
n *- -o >* "o o a CD O)
a. O rtJ w— C i— o £ •<-
in >> <o Ja TD TO JD a) <o j5 U)
10 <—
-M -* -P -* -p (D C
+J •^ C O CD CD C O CD 0) c o O) I- O
4- c <o O -P o (D O-P O 0) O -P O <0 C
O CD T3 t- o * »- O * T- O
1 -P >> V >> P >, t_in w CD Q-i— CD CL«— CD CLi— in o
+j I- D) E i- L. O) S — i- OlE^ £_ 0)
uj o => » 3 Q CD (O 3 ra o (0 3 <0 9 3 ^->
_l U) U U1Q Q- i- Ul Q D_ l in Q Q_
Sfc lO CD C © c 0) c rO O8 > O > O > o >• •
\- UJ 2: < (J < u < o * O
o in
£ CD
j2i
<a
-P h-
c
Q X
O Q
4- C
C a.
01 a.
<
+1 c P
(0
m IS
o\ <a XJ
CD C
£_ •«-
-P
CD
L. f-
CN CD <0
B>
+i in
in p
CN -p o
r0 CD
en S- 4-
4-
a> ©
I_ *-»
O co
48
than rats that were not exercised, but these differences were not ob-
served during weekends. Aspartame supplementation did not significantly
affect total weekday feed consumption. However, when average weekday
(M-F) feed consumption was expressed relative to body weight, aspartame
groups had significantly less weekday feed consumption (P<.01).
An interaction between exercise and aspartame also was noted when
observing feed intake per lOOg body weight (Table 5) . Aspartame treat-
ment did not seem to influence feed intake in exercised rats; however,
non-exercised rats fed aspartame had lower daily relative feed intakes
than those not fed aspartame, (interaction, P<.b5).
Effects of Aspartame and Exercise on Body Fat Contents
The effects of aspartame and exercise on various body fat contents
of the rats studied are shown in Table 6. Exercised animals had
signif-
icantly lower (P<.01) percent total body fat and weights of fat depots
studied including epididymal fat, retroperitoneal fat, and abdominal fat.
This was observed even when fat depots were expressed per lOOg body
weight (with the exception of retroperitoneal fat, which did not show
a significant decrease in fat per lOOg body weight due to exercise)
.
Aspartame supplementation resulted in no significant effects on
body fat contents. Aspartame in combination with exercise also failed
to yield any effects on fat contents.
Effects of Aspartame and Exercise on Tissue Weights and Lipid Contents
The effects of aspartame and exercise on tissue weights and lipid
contents of rats in the 9 week study are shown in Table 7.
Liver . Exercised animals had smaller livers (P<.05) than non-exer-
cised animals. When expressed as percent of body weight, however, no
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treatments resulted in significant effects on liver size. Liver lipid
contents also were unaffected by either aspartame or exercise.
Kidney. Both exercised rats and aspartame -supplemented rats had
larger kidneys (P<.05) than control rats, even when considering kidney
weight relative to body weight. The combination of aspartame and ex-
ercise did not have a significant effect on kidney size.
Lipid contents of kidneys were lower in exercised rats (P<.05) and
aspartame treatment did not have any significant effect on this measure-
ment.
Heart Heart weight and lipid contents of heart tissue were not
significantly altered by any of the experimental treatments.
Effects of Aspartame and Exercise on Muscle Weights and Lipid Contents
The effects of aspartame and exercise on weights and lipid contents
of muscles are shown in Table 8.
Vastus medialis. The vastus medialis weights were not significantly
affected by any of the experimental treatments. However, when muscle
weights were determined as a percent of body weight, the vastus medialis
of exercised animals was larger (P<.01) than those of non-exercised
animals. Also, fat contents of the vastus medialis were lower in exer-
cised animals.
Vastus lateralis . Exercised rats had larger vastus lateralis
muscles relative to body weight (P<.0S) and lower fat contents of these
muscles (P<.05) than did non-exercised rats. Aspartame alone did not
affect the muscle weights or lipid contents of this muscle. However,
an interaction was shown between aspartame and exercise. Aspartame-fed
rats had heavier vastus lateralis muscles than did rats which were not
52
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exercised. This was observed even when muscle weights were expressed
on a lOOg body weight basis.
Gastrocnemius medialis . None of the experimental treatments sig-
nificantly affected the weights or lipid contents of the gastrocnemius
medialis of the rats.
Gastrocnemius lateralis . Differences between groups for this
muscle were similar to those observed for the vastus lateralis. Aspar-
tame or exercise alone did not affect the muscle weights. Lipid contents
of the gastrocnemius lateralis were lower in exercised animals (P<.05).
A significant interaction was noted between aspartame and exercise where
the non-exercised rats fed aspartame had lighter muscles than non-exer-
cised rats not receiving aspartame. These differences also were ob-
served when muscle weights were relative to body weight.
Effects of Aspartame and Exercise on Serum Cholesterol, Triglycerides
and Glucose
The effects of aspartame and exercise on serum lipids and glucose
are shown in Table 9. Serum total cholesterol, LDL cholesterol, and
triglycerides were lower (P<.05) in exercised animals. However, aspar-
tame did not seem to affect any of these measurements.
Glucose levels were not significantly affected in any treatment
groups.
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DISCUSSION
Exercised animals in this study gained significantly less weight
than the sedentary animals. Others (143-146) also have shown that ex-
ercised rats gained less weight than sedentary controls. At least two
studies (145,146) report similar findings with human subjects.
Exercise also significantly decreased feed intake even when feed
intake was calculated relative to body weight. Several previous studies
support these findings. Katch et al. (143) showed that exercised rats
had lower feed consumption than nonexercised rats. Mayer et al. (145)
observed that rats exercised for 20 min to 1 h had lower feed intakes
and body weights than sedentary rats.
The lower weight gains and feed intakes were observed specifically
during the weekdays when rats were exercised. Exercise thus seems to
have an inhibitory effect on appetite, although perhaps temporarily, in
that the suppressing effects were not observed on weekends.
Exercised animals had a lower percent body fat as well as lighter
fat deposits when compared to nonexercised animals. Percent body fat
was lower in exercised groups and epididymal, retroperitoneal and ab-
dominal fat deposits also were lighter in these groups. Wahlberg et
al. (144) and Crews et al . (142) also showed that exercised rats had a
lower percent body fat than sedentary control animals. Both Askew et
al. (147) and Oscai et al . (148) reported a reduction in epididymal fat
pad weights in response to exercise. Burowrecki et al. (149) showed that
exercised male rats had EFP weighing 50-55% less than control rats. A
study by Lau et al . (150) showed that retroperitoneal fat was 50% lower
in exercised groups in comparison to that measured in sedentary groups.
56
Exercise did not significantly affect lipid contents of tissues
other than the kidney in this study. Kidneys of exercised rats were
lower in lipid contents when compared to kidneys of rats in other treat-
ment groups. Exercise did result in lower lipid contents of three of
the four muscles studied. (Lipid contents of the gastrocnemius medialis
were unaffected by exercise.)
The lower serum total cholesterol and triglyceride levels observed
in exercised rats in this, study are similar to data reported for exer-
cised rodents in other studies (151-154). The LDL and HDL cholesterol
levels also were determined in this study using affinity columns. How-
ever, the sum of these two fractions frequently resulted in recovery
exceeding 100%, so the reliability of the assay procedure is questionable.
The affinity columns were originally tested for human clinical analysis
(telephone communication with Isolab, Inc., Akron, OH), and it is possible
that rat serum may have substances which interfere with the assay pro-
cedure.
The reason for lower relative feed intakes by the aspartame-fed
rats is not clear. Both control and aspartame supplemented diets were
isocaloric. The 0.6% aspartame in the experimental diet replaced 0.6%
cornstarch in the control diet. Both dietary components have approxi-
mately 4 calories per gram. A recent theory is that the taste of sweet-
ness such as that imparted by saccharin results in a release of insulin
even though no calories are provided (157) . It is not known whether rats
perceive sweetness the same way as humans do. However, if a sweet taste
were provided continually, it is possible that hormonal responses might
be altered in such a manner that the animals would handle energy differ-
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ently. However this is speculative, and there is at the present time
no good explanation for these data. It should be investigated further
in view of the fact that aspartame is now a popular dietary aid.
In this study aspartame treatment had other effects as well as
those mentioned previously. Aspartame-treated rats had larger kidneys
even when expressed as a percent of body weight. This finding also was
noted by Hiroyuki et al . (156)
Muscle weights also were studied. An unexpected interaction was
noted between aspartame and exercise on weights of vastus lateralis
(thigh) and gastrocnemius lateralis (calf) muscles. Rats which were
exercised and fed aspartame had heavier vastus lateralis muscles than
exercised rats not fed aspartame. However, this difference was not
observed in non-exercised rats. An interaction also was noted for the
gastrocnemius lateralis muscle where aspartame affected muscle weights
differently depending on whether or not the rats were exercised. As-
partame-supplemented rats that were exercised had larger gastrocnemius
lateralis weights than aspartame-supplemented rats that were not exer-
cised.
The differences in muscle weights could not be attributed to dif-
ferences in muscle lipid content. Muscle is primarily water, containing
as its second most important component (by weight) protein. However,
water and protein were not determined in this experiment.
Aspartame is still a relatively new sweetener and much is still
not known about its effectiveness in weight control. There are rela-
tively few published studies involving rodents and those that exist
vary with respect to dosage, age and strain of animal used, length of
trial, and manner in which the aspartame is administered.
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The estimated maximum dosage for humans at
the 99th percentile is
34 mg aspartame per kg body weight (5). However,
rat trials have
utilized much higher dietary concentrations.
Yokogoshi et al
.
(155)
administered 200 mg/kg body weight to fasted rats.
Hiroyuki et al
.
(156)
gave rats either 1000, 2000, or 4000 mg/kg body weight
for 104 weeks
for a toxicological study. The rats in this
study were fed aspartame
at a level of 0.6% of their normal diet which
is approximately 500 mg/
kg body weight. This level was chosen because
it was a realistic con-
centration to feed as a part of the normal diet
for a 9-week period.
There are not many rat trials on which to base
an "ideal" dietary level
of aspartame; however, the amounts chosen
were less than those employed
in the toxicity study cited.
An interesting finding in this study was
that even though aspartame-
fed rats gained the same amount of weight as
those not supplemented, they
consumed significantly less feed, and hence
calories. One might surmise
that aspartame fed at this level makes rats
more calorically efficient,
so fewer calories are required to maintain the
same body weight. This
unfortunately seems to be counterproductive to a
primary reason for con-
suming aspartame - to lose weight by creating
a calorie deficit. It is
important to note that the effects of aspartame on
feed intake were ob-
served primarily in non-exercised rats. The
exercised rats fed aspartame
had feed intakes similar to those not exercised.
SUMMARY
The effects of aspartame and exercise on feed intake, weight
gain, body composition, percent body fat and tissue lipid levels were
studied in growing male Wistar rats. Comparisons were made within a
2x2 factorial design (n=9) where the main treatment effects were
treadmill exercise (24 meters/min for 75 min/day, 5x/wk, 9 wks) , and
aspartame (0.6% in a nutritionally adequate purified diet).
Exercised rats gained less weight, had lower percent body fat,
lighter fat pads (epididymal, retroperitoneal, and abdominal), less
intramuscular fat (vastus lateralis, vastus medialis, and gastrocnemius
lateralis), and lower serum cholesterol and triglyceride levels. Ex-
ercised rats also consumed less feed relative to body weight throughout
the trial. Aspartame-treated rats had similar lipid contents in all
tissues studied when compared to those not receiving aspartame. How-
ever, relative feed intake was significantly less in aspartame-fed rats.
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APPENDIX TABLE 1
Request for aspartame from the Searle Company
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REQUEST FOR ASPARTAME
Name Dr. Katharine K. Grunewald Date 11/25/84
Institution Deot. Foods and Nutrition, Justin Hall
Address Kansas State University
Manhattan, Kansas 66506
Phone Number (913) 532-5508 (office) or (913) 532-7010
Title or Function Assistant professor (nutrition) ^^
Outline of Work to be Done:
The overall objective of the proposed study is to determine if aspartame
supplemented-rats respond to exercise in a manner similar to those not fed
aspartame. This objective will be accomplished by comparisons within a 2 x 2
factorial design (n*9) where the main treatment effects will be treadmill
exercise (30 meters/min for 1 hr/day, 5x/wk), and aspartame (0.6% in an ade-
quate AIN-76A, starch-modified diet). During the planned 3-week study the
animals' voluntary feed intake and weight gain will be measured and feed effi-
ciency will be calculated. At the end of the study the rats will be sacri-
ficed and % body fat will be determined by hydrostatic weighing. Tissues
affected by exercise will be weighed and composition will be determined:
heart, lungs, liver, epididymal fat pads, kidneys, and 3 skeletal muscles from
the hind legs. The muscles studied will include soleus (red, slow-twitch),
extensor digitorum longus (white, fast- twitch)-, and anterior tibialis (mixed).
We know that approximately 25 kg feed is needed to feed 18 young growing rats
for 3 weeks and are requesting 150g aspartame to achieve a 0.6S aspartame diet.
Professional Hi
5
zcry
Degree B . 5 . ( nutri ti on
)
Degree ^-S. (nutrition)
University ^^- of Wis. Date 5/7-1
University U"*v- Qf <y- Date & 76
Degree ph-D. (animal nutrition) university L,n1v - of <y- Date 8 ^ 79
Relevant Publications : 1) Grunewald. K.K. and T.J. Tucker. 1984. Gastric emptying
in exercised mice. Comp. tJiocnem. Physio', in press. 'i) buiounan, k., k.k. jmnexa i.r~
and R.R. Haack. 1984. Effects of exercise duration on feed intake and boay composition
of 5wiss albino mice. J. Appi. Hhysiol.: Xespirat. environ, exercise i-nysioi. ;n trsba.
I agree that I will hold harmless G.D. Searle 6 Co
.
, its subsidiaries,
officers, directors and agents from any and all liabilities which may
attach or flow from the above use of aspartame, including costs and
attorneys' J.ees «-, if _any,~. « I
Signature NUMl.1 i h jfa&&£L Date 11/25/84
Katharine' K. Grunewald
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APPENDIX TABLE 2
Reply from the Searle Company
Swsna fooa Reiourcei Inc.
Suond-trv of CD. Setns & Co.
Bom fltl
Sio*,; ll/inois 60076
Telex 23-430
March 21, 1985
Dr. Katharine K. Grunewald
Dept. Foods and Nutrition, Justin Hall
Kansas State University
Manhattan, Kansas 66506
SEARLE
Dear Dr. Gruenwald:
We have enclosed an additional sample of aspartame per your
request. We again ask that you please:
a) Periodically inform us of your progress,
b) Provide to the Office of Scientific Affairs,
NutraSweet* Group, your data for review and
comment prior to submission for publication.
If I can be of any further assistance please let me know.
Sincerely,
Daniel J.'-Skryp^bi Ph.D.
Scientific Affairs Analyst
HutraSweet* Center
DS:nlc
Enclosure
m
7.,
APPENDIX TABLE 3
Density of water at different temperatures
density of water at
different temperatures*
Temperature D wf
(°C) (grams/ml.)
21 0.9980
22 0.9978
23 0.9975
24 0.9973
25 0.9971
26 0.9968
27 0.9965
28 0.9963
29 0.9960
30 0.9957
31 0.9954
32 0.9951
33 0.9947
34 0.9944
35 0.9941
.36 0.9937
37 • 0.9934
38 0.9930
39 0.9926
40 0.9922
"Extracted from Weast. R. C. (Ed.): Handbook of Chemistry and Physics, 54th ed.. Cleve-
land: The Chemical Rubber Company, 1967, p. F-11.
fRounded to 0.0001.
7
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APPENDIX TABLE 4
Determination of serum cholesterol (total, HDL, and LDL)
Isolab LDL-Direct Cholesterol Audit System Cholesterol Standards
#QS-8160 (60 test) Dow Diagnostics
Isolab Inc. Tne Dow Chemical Company
Innovative Biochemical Methodology Indianapolis, IN 46268
Drawer 4350 200 mg/dl
Akron, OH 44321 800-321-9632
I. Separation of alpha and beta fractions (HDL and LDL cholesterol)
1. Remove first the column's top cap, then the bottom closure.
This order of opening is important - otherwise air will enter
the column tip, interfering with free liquid flow.
2. Use the wide end of a Pasteur pipette to push the upper disc
down until it contacts the top of the resin bed. Do not
compress bed.
3. Allow the column to drain until the liquid level reaches the
top disc, where flow will automatically stop.
4. Check to determine whether air may have entered the column
during shipment. A few small air bubbles will not affect
its performance. However, large volumes of air should be
removed by tilting the top disc until the bubble escapes,
then returning the disc to its original position.
5. Equlibrate the column bed by adding 1.0 ml of Alpha Fraction
Elution Agent (Reagent #1) to the column. Allow column to
drain. Discard eluate.
6. With the column positioned over a test tube (12 x 75mm, 5 ml),
add 0.2 ml serum to the column, near or on the upper
disc. Collect the eluate.
7. Add 1.0 ml of Alpha Fraction Elution Agent (Reagent #1) and
collect the entire volume in the same test tube, for a total
fraction volume of 1.2 ml. Mix well.
8. Place the column over a clean 12 x 75 mm tube.
9. Add 1.2 ml of Beta Fraction Agent (Reagent #2) and collect the
entire volume. Mix well.
Fill column with saline or eluted Alpha Elution Reagent, recap
and store for possible regeneration.
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APPENDIX TABLE 4 (cont'd)
II. Quantitation of cholesterol (total, HDL, and LDL)
Incubator at 35 C
Cholesterol reagent should be reconstituted (50ml deionized dis-
tilled water/bottle) several hours or overnight before assay.
Disposable glass tubes 12 x 77 ram (5 ml culture tubes)
A. Dilution of standards and serum for total cholesterol (1:6 to
match dilution of alpha and beta fractions during separation).
1. Pipette 0.2 ml of each STANDARD (200 mg/dl) or SERUM SAMPLE
for total cholesterol into tubes.
2. Add 1.0 ml SALINE to each of the above tubes and vortex.
B. Cholesterol Determination
1. Pipette 0.12 ml saline for blank (or distilled water)
0.12 ml diluted serum for total cholesterol
0. 12 ml diluted standards
0.12 ml alpha fraction
0.12 ml beta fraction
(run duplicates of each, except blank, but you may need
more cholesterol reagent than is provided in the kit).
2. To each tube add 1.0 ml cholesterol REAGENT
Cover with parafilm and invert several times to mix (gently)
3. Incubate all tubes at 37 C for 12-15 minutes.
4. Following incubation, add 1.0 ml SALINE to all tubes and
vortex gently. (can add 2.0 ml saline to increase volume
to 3 ml to read in Spec. 20).
5. Read BLANK - 100% transmittance, 0% absorbance as ref-
erence at 545 nm (directions indicate 500 + 15 nm but
Brinkmann probe has filter at 545nm). Read and record
absorbance of STANDARD and SAMPLES
.
COMPLETE ALL READINGS WITHIN 30 MINUTES OF INCUBATION
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APPENDIX TABLE 5
Computer program for statistical analyses
//mlT«»«» JO* (J916M2.57,SFa«E62,,7),'DIAKNA',TINE-<1,59>
/"REGION 6U0K
// EXEC SAS
//SYSIN 00 *
data aspartam;
lilhl 5?!! £IL2£tI? £ ?£15 e , ani> *sp»rta«e in growing hale rats;INPUT <ID EXERCISE ASFART PIONWM S ATKT1 P10NWT2 SATWT2 HONyT3 SATKTJ;o;yr* satuta noNyrs SAiyrs No^yre SATyT6 «0Nyr7 satjt? NONyra!AryT« homwT9 SAryr9 pffoi ssfbi mffd2 ssfd2 piffd3 sspoi mffoaJSF04 HFFD5 SSF05 HFF06 SSF06 1FFO 7 SSF07 NFFD8 3SF08 NFFD9
JOOYFAT LIVER HONEYS HEART A830NF AT EPIOFAT RETROFAT GASTROCL
IJSTROC^VASTUS^VASTLSMXJ. 2*1. U»S. J.A.I J.l 11. All 3.1 4.2
T0T6AIN-SATyT9-H0NyTl; OAT 6AIN»T5T SAIN/61;
;FSAIN1-SATyTJ-«ONyTl; SS6AIN1=nONyT2-SATWTi;
BFGAIN2-SATyT2-HONyT2; SSG AIN2=H0N yT3-SATUT2;
KF«AIN3-SATyT3-N0NyT3; SSGA INJ=HON yT4"SATWT3;
BFGAIN*«SATyT4-P10NyT4; SSG AINA'NON yTS-SATWr*;
MFGAINS-SATWrS-IIONyTS; SS6 AIN5*NQN yT6-SATyT3;
HFGAIN6-SATyT6-H9NyTo; SSGAIN6-HON yT7-SATyT6;
HFGAIN7=SATyT7-ftONyT7; SSGAIN7'«ONyT8-SATUT7;
HFSAINB-SATMra-KONyTa; SSGAINa-H3NyT9-SAryT8;
HFGAIN9-SATyT9-flONyT9;
AVPJFGAIN.<NFGAIN1.HFGAIN2*HFGAIN3*HFGAIN4*NFGAINS*HFGAIN6.
NFGAIN7*HFGAIN8»NFGAIN9)/«>;
AVSSGAIN-(SSGAIN1«SSG*IN2«SSGAINJ*SSGAIN**SSGAIN5*SSGAIN6*
SSGAIN7*SSGAIN8) /16;
TOTHFFO«BFF01*NFF02»MFF03tHFF04*1FFOS*«FF06*NFF0 7»HFFOa+«FF0 9;
T0TSSF0»SSFD1+SSF0 2*SSF0i.SSFDi*SS FD5.SSFD6.SS F0 7*SSFD 8;
a!"rFEEoI<TOTFO)/61- ' VS.Sf0
" <"TSSF0,/16; TOTFO»TOTHFFO*TOTSSFO;
LI»ERPER=(LIVER/SAryT9)»100; «OPER"<KI0NETS/SATyT9)»10O;
HRTPER=(HEART/SATyT9)«100; GASTLPE R-<GASTROCL/ SATW T9) «1 00;
SlfSSfI5^RlTg3FjTT ;!;{2T?S:,uu! «
> »'"-«l >»'*«»T«9|.100;
depofat=abdomfat*epidfat*r£trcfat;
llii'Hi'i'HlilW.imUi FoyTssi-<ssFoi/2)/SATyn; F0yTNFz.<HFFD2/5 )/"ONyT2;Ft>yTss2«(ssFD2/2)/sATwr2; FDyiiFj=<MFFD3/5)/",ONyr3; FoyTss3=(ssF03/2)/s*Tyr';
!S yI nEJ*S? F E D i /,5 > <"0Nkr * ; FOyTSS*=.<SSFOA/2i/SATyrA; FDMTMF5 = (HFFD5/5)/HONyT5;
ii UUii'iiWi'.il'. iAT"V fOy»F4=<NFF06/5)/HONyT6; F0yTSSO«(SSFD6/2)/SAT.T6;FpyTNF7=(HFFD7/5)/NONkr7; FDJISS7= (SSF07/2) /SA TWT7; FO XT«F8-<"!FFOa/5 >/NONyT8;
FDyTSS8-<SSFD8/2)/SAT»T8; FDyHF9=<MFF09/5)/NONyT9;
AFUTFD = <FgyTP1F1»fDyTHF2-fF0WTMF3*FDyTNF*.*FDyTHF5.F0yTHF6.FDyTMF7»
-SIKTF0"<F0yTSS1*F0yISS2»FD«TSS3*FDyTSSA*F0UTSS5*F0yTSS6+F0yTSS7t
r TSSo ) / Qo
J
AVyTFD = ((HFyTF0»*S)*<SSyTF0«12))/6 1;
If ?JI! CJISm1 ^°rJ S ?J*I i1 THf SKOUM1J IF EXERCISE-1 AND ASPART=2
cards; -
saod oe data
DATA SyCET;
ik»ut~{id llvfat kiofat hrtfat vnf at vlfat ofit glfat tg
totchol ldl hdl euic3. a. 2 6*3.2 3. 3*3.1 3.};
cards;
SADD DATA Dc
DATA ALU" MERGE ASPASTAM SyEET; 31 10!
proc sort; ar group; froc prim; ai group;
PIOC HEANS; BY GROUP; VAR NONUM -- VASTUSH TOTGAIN OAYGAIN
AVF1FGAIN AVSSGAIN AVHFFO AVSSFD AVERFcED TOTFD LIVERPER HOPES
HRTPER 6ASTLPES GA5TPIPER VAiTLP ER VASTHPER OEPOFAT
LIVFAT—GLU ABOONPER EPIDPER RETROPER HFWTFD SSUTFD Al/UTfo;
PIOC ANOVA; CLASSES EXERCISE AiPART;
MODEL HON.T1 SATJT9 TOTGAIN OAfGAIN AVHFGAIN AVSSGAIN AVHFFD AVSSFD
TOTFD AVERFEED 300YFAT LIVES lIVERPER KIDNEYS KIDPER HEART
HRTPER GASTROCL GASTLPER GASTROCH GASTHPER VASTUSL VASTLPER
VASTUSH VASTMPER OSPOFAT LI/FAT KIDFAT HRTFAT ABOOHPER cPIDPER
RETROPER NFyTFO SSkTFO AvyTFO A BOONFAT EPIOFAT RETROFAT
VPIFAT VLFAT GNFAT SLFAT TG TOTCHOL LDL HDL GLU'EXERCISE
ASPART EJtERCISE.ASFART;
/•
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APPENDIX TABLE 6
Effects of aspartame and exercise on nine-week weight gains of growing male
rats.
Measurement
Initial weight
-Exercise
-Aspartame +Aspartame
+Exerc1se
-Aspartame +Aspartame
_g
Final weight-
Weight galn-
-71
57
66
64
58
69
67
106
61
69±5*
496
421
400
412
423
437
469
475
422
439+11
-425
364
334
348
365
368
402
369
261
371+9
70
50
72
65
59
70
83
82
13.
70+4
403
442
460
500
380
430
450
510
451
447±14
333
392
388
435
3 21
360
367
428
222
377±13
68
61
59
56
95
83
92
62
22
72+5
423
428
368
387
404
418
427
415
440
412±8
355
367
309
331
309
335
335
353
2£2
340+7
57
78
66
54
90
75
65
63
11
69±4
416
424
396
476
424
385
404
414
445
420+9
359
346
330
422
334
310
339
351
220
351111
Results are expressed as means + SEM for 9 rats In each group.
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APPENDIX TABLE 7
Effects of aspartame and exercise on average dally weight gains of growing male
rats
-Exercise +Exerc1 se
Measurement -Aspartame +Aspartame -Aspartame +Aspartame
7.0 5.5 5.8 5.9
6.0 6.4 6.0 5.7
5.5 6.4 5.1 5.4
5.7 7.1 5.4 6.9
6.0 5.3 5.1 5.5
6.0 5.9 5.5 5.1
6.6 6.0 5.5 5.6
6.0 7.0 5.8 5.8
5_i2 £Ju 6.0 fiU.
6.1+.1* 6.2+.2 5.6+.1 5.8+.2
Average weekday (M-F) ga1n# 7.0 7.9 5.3 5.4
6.1 6.9 5.7 5.2
5.1 6.2 4.8 4.7
5.9 6.8 4.7 6.6
5.9 3.7 4.9 4.8
6.3 5.5 4.7 4.7
6.6 5.6 5.1 4.8
6.0 6.8 5.1 5.0
5^3 6^2 L& 5j2.
6.1+.2 6.2±.4 5.1+.1 5.2+.2
Average weekend (S-S) ga1n# 6.9 -1.5 7.2 7.2
5.6 5.1 6.9 6.9
6.5 6.9 5.8 7.5
5.2 8.2 7.4 7.9
6.3 9.6 5.4 7.3
5.2 7.1 7.6 6.2
6.6 7.1 6.6 7.8
6.2 7.6 7.6 7.8
6.0 6.0 2*2 SA
6.1+.2 6.2+1.0 6.9+.3 7.4+.2
Results are expressed as means + SEM for 9 rats 1n each group.
#Rats were exercised on weekdays (M-F) and rested on weekends (S-S).
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APPENDIX TABLE 8
Effects of aspartame and exercise on average daily feed consumption of growing
male rats
Measur ement
Average dally feed
consumption - -
Average dally feed consump-
tion per lOOg body we1ght#
-Exercise +Exerc1se
-Aspartame +Aspartame -Aspartame +Aspartame
?A K 19.0
20.8
18.6
19.9
19.3
20.121.7
20.3 20.5 18.6 18.6
21.3 24.2 18.2 21.9
20.4 18.9 19.4 20.5
23.2 23.0 19.3 17.7
22.7 22.5 21.7 19.4
23.0 22.5 20.4 19.0
21.9 20.9 21*1 ZLJ.
22.1+.5* 21.4±.6 19.71.4 19.71.4
- - 9.8 8.6 8.1 9.0
10.2 9.9 9.2 8.3
9.5 8.9 9.8 8.7
9.7 9.6 9.1 9.7
9.8 9.0 8.1 8.5
10.3 9.6 8.4 8.3
10.4 9.0 9.2 9.0
8.5 8.3 8.9 8.6
10.0 8,4 8.6 8.6
9.8+.
2
9.0+.2 8.8+.2 8.7+.1
Results are expressed as means 1 SEM for 9 rats 1n each group.
^Relative feed Intake calculated at end of each weekday or weekend period by
dividing average dally feed consumption for that period by body weight for
that period.
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APPENDIX TABLE 9
Effects of aspartame and exercise on average weekday (M-F) feed consumption of
growing male rats
-Exercise
-Aspartame +Aspartame
+Exerc1se
-Aspartame +Aspartame
Average dally weekday feed
consumption - - - - 24.1
21.4
19.9
21.1
20.0
23.0
22.1
22.7
21.8
21.8+.5*
18.5
20.1
19.6
23.1
17.8
22.0
21.4
21.8
2SLZ
20.5±.6
17.4
18.8
17.4
17.1
18.6
17.8
20.5
19.3
18.5±.
18.2
18.8
17.5
20.7
19.2
16.9
18.3
17.9
19.8
18.6+.4
Average dally weekday feed
consumption per lOOg body
weight # - — - 10.0 8.8 8.0 8.9
10.5 10.1 9.1 8.1
9.7 8.7 9.6 8.5
10.0 9.5 8.9 9.6
10.0 8.8 8.0 8.1
10.6 9.4 7.8 8.2
10.5 8.8 8.8 8.8
8.5 8.2 8.8 8.4
10.3 SlA &*s. a^
10.0+.2 9.0+.2 8.6+.2 8.5 +
Results are expressed as means ± SEM for 9 rats in each group.
#Calculated on a weekly basis where average dally weekday feed consumption was
expressed 1n terms of the Initial Monday body weight.
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APPENDIX TABLE 10
Effects of aspartame and exercise on average weekend (S-S) feed consumption of
growing male rats
-Exercise +Exerc1se
Measurement -Aspartame +Aspartame -Aspartame +AspartaiHS
g
Average dally weekend feed
consumption -25.
5
20.5
22.5 22.9
21.4 23.0
21.7 27.3
21.6 22.3
24.0 25.8
24.3 25.7
23.9 24.8
22JL 22*2.
23.0±.5* 23.9+.7
21.9 22.4
23.1 23.5
22.2 21.6
21.4 25.2
21.8 24.0
23.5 20.1
24.8 22.6
23.5 22.1
2.<L3_ 24*2
22.9±.4 22.9+
Average dally weekend feed
consumption per lOOg body
we1ght#- --------- 9.3 8.3 8.6 9.4
9.3 9.5 9.5 9.0
9.1 9.3 10.6 9.1
9.0 9.9 9.7 9.9
9.1 9.7 8.5 9.5
9.5 10.1 10.0 8.8
10.2 9.8 10.2 9.7
8.2 8.4 9.2 9.0
2A. 8^5. 8.8 2J.
9.2+.
2
9.3 + .
2
9.5+.
2
9.3+.
1
Results are expressed as means + SEM for 9 rats 1n each group.
#Calculated on a weekly basis where average dally weekend feed consumption
expressed 1n terms of the Initial Saturday body weight.
S5
APPENDIX TABLE 11
Effects of aspartame and exercise on percent body fat of growing male rats
-Exercise +E,x.erc1se
Measurement -Aspartame +Aspartame -Aspartame +Aspa.rtame
Body fat 14.2
17.5
14.0 19.5
18.0 22.6
10.4 18.7
17.5 19.5
20.7 21.1
19.1 19.5
16.3 18.7
16.4+1.0* 19.4+.7
14.2 11.2
13.2 11.2
10.8 9.6
17.1 14.0
12.4 13.6
17.1 14.4
18.3 20.7
15.2 13.6
14.0 lid
14.7+.8 13.9+1.1
Results are expressed as means + SEM for 9 rats 1n each group.
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APPENDIX TABLE 12
Effects of aspartame and exercise on epldldymal fat of growing male rats
-Exercise +Exerc1se
Measurement -Aspartame +Aspartame -Aspartame +Aspartame
g
Epldldymal fat weight 6.4 7.0 4.5 5.5
5.8 5.1
4.7 4.1
5.0 6.9
4.2 6.9
6.4 4.2
7.8 6.4
4.0 4.0
5^2 Z*2
5.4+.4 5.6±.4
Epldldymal fat weight per
lOOg body weight 1.3 1.7 1.1 1.3
1.4 1.2
1.3 1.0
1.3 1.4
1.0 1.6
1.5 1.1
1.8 1.6
1.0 0.9
1*6 LiS La 1,6
1.5+.1 1.8+.1 1.3+.1 1.3+.1
*Results are expressed as means + SEM for 9 rats 1n each group.
•
6.6 5.6
3.6 8.0
6.3 12.8
5.1 5.2
5.7 8.8
10.7 9.1
8.7 10.0
6.6 aa
6.6+.7* 8.3;
1.6 1.3
0.9 1.7
1.5 2.6
1.2 1.4
1.3 2.0
2.3 2.0
1.8 2.0
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APPENDIX TABLE 13
Effects of aspartame and exercise on retroperitoneal fat of growing male rats
-Exerc ise +Exer else
Measurement -Aspartame +Aspartame -Aspartame +Aspartame
Retroperitoneal fat weight - - - 8.8 10.0 3.3 4.8
11.2 7.8 7.2 4.9
5.3 12.7 7.0 3.6
7.3 16.7 4.8 8.1
S.4 6.3 3.3 7.4
11.8 11.2 7.7 5.2
14.4 12.4 7.8 7.0
10.8 13.0 7.1 3.4
<L2. I2J1 6^1 ia
9.1±1.0* 11.311.0 6.11. 6 5.71.6
Retroperitoneal fat weight per
lOOg body weight 1.8 2.5 0.8 1.2
2.7 1.8 1.7 1.2
1.3 2.8 1.9 0.9
1.8 3.3 1.2 1.7
1.3 1.7 0.8 1.7
2.7 2.6 1.8 1.4
3.1 2.8 1.8 1.7
2.3 2.5 1.7 0.8
1^ 2a2 L£ L^
2.11.2 2.5+.2 1.51. 1 1.41.1
Results are expressed as means 1 SEM for 9 rats 1n each group.
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APPENDIX TABLE 14
Effects of aspartame and exercise on abdominal fat of growing male rats
-i[xerdse +Exerc1se
Measurement -Aspartame +As par-tame -Aspartame +Aspartame
7 r 6.4 3.1 4.6
7.5 5.5 5.1 3.7
4.8 8.1 3.1 3.3
4.4 11.6 3.9 6.3
4.5 4.2 2.5 5.0
6.7 8.4 6.3 4.0
10.9 8.0 5.9 6.1
8.2 8.7 4.6 2.4
6^2 6.8 S_J. L.5.
6.7+ .7* 7.5+.7 4.4±.,4 4.5±.4
Abdominal fat weight per lOOg
• - 1.5 1.6 0.7 1.1
1.8 1.2 1.2 0.9
1.2 1.8 0.8 0.8
1.1 2.3 1.0 1.3
1.1 1.1 0.6 1.2
1.5 2.0 1.5 1.0
2.3 1.8 1.4 1.5
1.7 1.7 1.1 0.6
1*5. 1*5. Ll2 1*2
1.5± .1 1.7+.1 1.1±. 1 l.l+.l
*Results are expressed as means ± SEM for 9 rats 1n each group.
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APPENDIX TABLE 15
Effects of aspartame and exercise
mal e rats
on liver weight and lipid contents 1n growing
Measurement
Liver weight (g)
Liver weight per lOOg body
weight (g)- ------
Liver lipid contents (?
-Exercise
-Aspartame ^Aspartame
+Exerc1se
-Aspartame +Aspartame
•16.08 11.70 12.24 12.97
14.18 14.13 13.20 12.12
13.42 14.89 9.70 12.31
12.40 16.90 10.91 15.52
11.64 10.39 12.52 13.42
15.12 12.83 12.36 11.82
14.74 13.24 12.80 12.16
14.03 16.27 13.48 13.41
11.85 14.34 12*52 12.64
13.72+.51* 13.851.69 12.191.39 12.93
1.3 8
•3.24 2.90 2.89 3.12
3.37 3.20 3.08 2.86
3.36 3.24 2.64 3.11
3.00 3.38 2.82 3.26
2.75 2.73 3.10 3.17
3.46 2.98 2.96 3.07
3.14 2.94 3.00 3.01
2.95 3.19 3.25 3.24
2.81 3.18 2.85 2.84
3.12±.08 3.081.07 2.951.06 3.071.05
14.03 9.61 8.55 11.00
9.32 8.87 9.16 9.00
15.27 13.29 10.08 15.42
9.61 9.16 8.40 6.26
12.53 13.45 7.63 10.53
8.87 13.90 11.61 12.53
13.45 11.00 9.61 8.75
11.90 10.24 15.87 8.75
19.08 9J2 9.00 15.74
12.67 +1.1C i 10.981.68 9. 99+. 83 10.89
11.06
*Results are expressed as means 1 SEN for 9 rats 1n each group.
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APPENDIX TABLE 16
Effects of aspartame and exercise on kidney weight and lipid content 1n growing
mal e rats
+Exerc1se
Measurement -Aspartame i +Aspartame -Aspartame i +Aspartame
9 85 2.43 2.98 2.97
2.47 2.89 2.92 3.02
2.65 2.60 2.26 2.93
2.40 3.08 2.40 3.54
2.67 2.56 2.61 3.01
2.46 2.81 3.02 2.76
2.51 2.45 2.81 2.67
2.89 2.90 2.69 2.88
2.64 2.70 2.87 3.26
2.62±. 06* 2.71+.07 2.73±. 09 3.00±.09
Kidney weight (both) per lOOg
n 57 0.60 0.70 0.71
0.59 0.65 0.68 0.71
0.66 0.57 0.61 0.74
0.58 0.62 0.62 0.74
0.63 0.67 0.65 0.71
0.56 0.65 0.72 0.72
0.54 0.54 0.66 0.66
0.61 0.57 0.65 0.70
0.63 0.60 0.65 0.73
0.60±..01 0.6U.01 0.66+. 01 0.71+.01
Kidney lipid contents (.%) - - 7.51 7.63 6.90 6.68
7.94 7.00 6.75 6.20
6.43 6.83 6.64 6.52
7.12 6.50 6.58 6.36
7.24 7.00 6.62 6.18
6.87 6.43 6.59 5.63
6.10 6.46 6.32 6.39
6.74 6.90 6.58 6.39
6^3.2 L21 6.11 t
6.92+, 20 6.67+.21 6.57+. 08 6. 29+. 11
Results are expressed as means ± SEM for 8-9 rats 1n each group.
#Th1s sample was lost during analysis.
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APPENDIX TABLE 17
Effects of aspartame and exercise
mal e rats
on heart weight and lipid contents In growing
Measurement
Heart weight (g)
Heart weight per lOOg body
weight (g)- - -
Heart lipid contents (%)
-Exercise
-Aspartame +Aspartame
+Exerc1se
-Aspartame +Aspartame
1.40 1.29 1.35 1.32
1.33 1.45 1.33 1.34
1.22 1.29 1.19 1.23
1.37 1.58 1.23 1.44
1.21 1.19 1.24 1.33
1.42 1.27 1.55 1.17
1.41 1.16 1.18 1.36
1.61 1.45 1.20 1.31
1*24 1.38 1.45 1*42.
1.36+.04* 1.3 4±.04 1.3 0±.04 1.33+.03
0.28 0.32 0.32 0.32
0.32 0.33 0.31 0.32
0.31 0.28 0.32 0.31
0.33 0.32 0.32 0.30
0.29 0.31 0.31 0.31
0.32 0.30 0.37 0.30
0.30 0.26 0.28 0.34
0.34 0.28 0.29 0.31
0.29 0.31 0_,3_3_ iLi2
0.31+.01 0.3 0+.01 0.32±.01 0.32±.00
4.58 4.07 4.23 4.51
4.46 4.58 4.46 4.78
4.51 4.07 4.62 5.03
4.67 4.49 4.46 4.93
4.93 4.99 4.23 4.46
4.51 4.51 4.58 4.70
4.55 4.73 4.65 4.22
4.42 4.58 4.58 4.3 8
4.08 4.65 4.74 I
4.60±.06 4.52+. 10 4.51+.06 4.63+. 10
*Results are expressed as means + SEM for 8-9 rats In each group
#Th1s sample was lost during analysis.
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APPENDIX TABLE 18
Effects of aspartame and exercise on vastus medial 1s weight and lipid contents
in growing male rats
Measurement
Vastus medians weight (g)-
Vastus medial 1s weight per lOOg
body weight (g) - - — - -
Vastus medial 1s Hp1d contents
(%)-
-Exerd se lExerd se
rat-tame +/> spartame -
0.89
Aspartame +A
1.80
spartame
•1.50 1.45
1.24 1.19 1.30 1.48
1.49 1.49 1.28 1.43
1.21 1.18 1.21 1.41
1.46 1.17 1.27 1.31
1.31 1.27 1.18 1.40
1.19 1.21 1.27 1.22
1.3 4 1.43 1.42 1.32
L££ Ui U2 Las.
1.34±.04* 1 .24+.06 1.34+.06 1.37+.03
0.3 0.22 0.42 0.35
0.29 0.27 0.30 0.35
0.37 0.32 0.35 0.36
0.29 0.24 0.31 0.30
0.35 0.31 0.31 0.31
0.30 0.29 0.28 0.36
0.25 0.27 0.29 0.30
0.28 0.28 0.34 0.32
{L3J. 0.29 0.30 0.30
0.31+.01 0.28±.01 0.331.01 0.33+.01
3.05 2.56 2.04 2.53
4.62 3.46 3.17 2.48
2.92 2.77 3.04 2.88
3.03 4.08 2.65 2.76
2.67 2.94 2.33 2.45
2.97 2.88 2.91 2.62
3.27 3.22 2.88 2.44
3.08 2.88 3.06 2.60
2^2 3.62 2.60 2*H
3.16±.19 3. 16+. 16 2.74+.12 2.61+.05
*Results are expressed as means + SEM for 9 rats 1n each group.
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APPENDIX TABLE 19
Effects of aspartame and exercise on vastus lateralis weight and lipid contents
1n growing male rats
-Exercise +Exerc1se
Measurement -Aspartame +Aspartame -Aspartame +Aspartame
Vastus lateralis weight (g)- -
Vastus lateralis weight per lOOg
body weight (g) ------ -
Vastus lateralis lipid contents
1.80 1.31 1.24 1.84
1.32 1.55 1.46 1.66
1.54 1.60 1.16 1.69
1.61 1.54 1.48 1.82
1.85 1.57 1.33 1.49
1.59 1.50 1.54 1.69
1.35 1.47 1.51 1.3 8
1.45 1.66 1.58 1.75
1^2 L£2 hJA UL4
1.54±.06* 1.53+.03 1.45+.06 1.67+.05
0.36 0.33 0.29 0.44
0.31 0.35 0.34 0.39
0.39 0.35 0.32 0.43
0.39 0.31 0.38 0.38
0.44 0.41 0.33 0.35
0.36 0.35 0.37 0.44
0.29 0.33 0.35 0.34
0.31 0.33 0.38 0.42
!L22 0.35 0.39 0.39
0.35±.02 0.34+.01 0.35±.01 0.40+.01
2.67 2.45 2.77 2.74
3.99 2.81 2.67 1.93
2.53 3.15 2.96 2.71
3.56 3.72 2.48 3.02
2.60 2.77 2.58 3.07
2.59 2.44 2.53 2.44
2.54 3.43 3.03 2.82
2.84 3.17 2.46 2.36
3.01 3.17 ZJtl 2.76
2.93+.17 3.01±.14 2.68+. 07 2.65±.12
Results are expressed as means ± SEM for 9 rats 1n each group.
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APPENDIX TABLE 20
Effects of aspartame and exercise on gastrocnemius medial 1s and lipid contents
In growing male rats
Measurement
-Exercise +Exerc1se
-Aspartame +Aspartame -Aspartame +Aspartame
Gastrocnemius medial 1s weight
(g)
Gastrocnemius medial 1s weight
per lOOg body weight - - -
Gastrocnemius medial 1s lipid
contents --- — _---
1.32 0.95 1.02 1.22
0.97 0.91 0.94 0.97
1.10 1.40 0.88 1.11
0.96 1.02 0.92 1.11
1.24 1.02 0.93 1.10
0.99 1.04 0.97 1.10
0.95 0.98 1.04 1.01
1.08 1.16 1.21 0.92
1.08 Ldl 1.07 1.06
1.08±.04* 1 .071.05 1.001.03 1.071.03
•0.27 0.24 0.24 0.29
0.23 0.21 0.22 0.23
0.28 0.30 0.24 0.28
0.23 0.20 0.24 0.23
0.29 0.27 0.24 0.26
0.23 0.24 0.23 0.29
0.20 0.22 0.24 0.25
0.23 0.23 0.29 0.22
0.26 0^25. 0.24 0.24
0.251.01 0.241.01 0.241.01 0.251.01
3.12 2.65 2.69 2.63
3.07 2.52 3.17 2.36
2.92 2.13 2.86 2.48
2.62 2.47 2.49 2.68
2.77 4.27 3.00 2.50
2.78 3.08 2.60 2.29
3.3 8 3.27 3.52 2.95
2.97 3.16 2.08 2.24
2.12 2.43. 2J5_ 2.38
2. 86+. 12 2.891.21 2.75+. 15 2. 50+. 07
Results are expressed as means 1 SEM for 9 rats 1n each group
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APPENDIX TABLE 21
Effects of aspartame and exercise on gastrocnemius lateralis and lipid contents
in growing male rats
-Exercise +Exerc1se
Measurement -Aspartame +Aspartame -Aspartame +Aspartame
Gastrocnemius lateralis weight
(g) -- 2.14 1.47 1.51 1.85
1.49 1.41 1.50 1.51
1.77 1.70 1.23 1.71
1.64 1.48 1.47 1.58
1.87 1.49 1.72 1.62
1.68 1.61 1.48 1.54
1.46 1.55 1.61 1.47
1.73 1.80 1.75 1.64
1.75 1.54 LJiS. 1.65
1.73±.07* 1.56+.04 1.54±.05 1.62±.04
Gastrocnemius lateralis weight
per lOOg body weight (g) -
Gastrocnemius lateralis lipid
contents (g) - ------
•0.43 0.36 0.36 0.44
0.35 0.32 0.35 0.36
0.44 0.37 0.33 0.43
0.40 0.30 0.3 8 0.33
0.44 0.39 0.43 0.38
0.38 0.37 0.35 0.40
0.31 0.34 0.38 0.36
0.36 0.35 0.42 0.39
0.41 0.34 0.35 0.37
0.39±.01 0.35±.01 0.37+.01 0.3 9±.01
2.35 3.74 2.12 2.85
3.54 3.25 3.05 2.43
2.85 3.37 2.42 2.81
2.51 3.56 2.80 2.61
2.94 2.61 3.46 3.25
3.00 3.41 3.25 2.97
3.29 3.25 3.13 2.96
3.31 2.93 2.88 2.23
2*25. 2.97 2.36 2.79
2. 95+. 13 3. 23+. 12 2. 83+. 15 2. 77+. 10
•Results are expressed as means + SEN for 9 rats in each group.
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APPENDIX TABLE 22
Effects of aspartame and exercise on serum HDL, LDL, and TOTAL cholesterol
in growing male rats
Measurement
-Exercise +Exercise
-Aspartame *Aspartame -Aspartame
- -
- -
-mg/dl- - - -
+Aspartame
HDL cholesterol 37.2
24.8
28.8
24.7
22.5
26.1
29.5
21.2
26.9±1. ±4.5
21.6
35.4
37.7
37.0
21.6
13.9
24.1
29.1
23.7
27.1±2.7
14.3
24.4
12.4
29.0
25.3
24.9
12.5
24.1
26.1
21.4±2.2
LDL cholesterol 51.5
52.0
49.4
41.2
34.7
45.3
41.5
29.5
43.1±2.
20.4
33.5
35.3
44.0
40.7
40.0±4.2
35.9
47.4
42.3
41.2
33.9
26.5
36.3
39.0
25.3
36.4: 2.4
28.5
30.3
28.8
32.2
26.1
27.4
27.0
30.3
29.5
28.9: 0.6
Total cholesterol 79,
76,
65.
57,
55,
65
69.7
50.6
65.0±3.6
50.1
84.6
76.8
32.2
56.3
50.6
87.6
80.5
64.8±7.1
44.1
74.5
72.2
40.0
58.4
43.3
60.6
63.9
49.8
56.3±4.2
63,0
44.1
41.2
54.3
49.8
47.8
42.7
52.3
54.4
49.9±2.
•Results are expressed as means ± SEM for 9 rats in each group.
tCould not draw blood from these rats.
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APPENDIX TABLE 23
Effects of aspartame and exercise on serum triglycerides and glucose in
growing male rats
Measurement
Triglycerides
-Exercise +Exercise
-Aspartame Aspartame -Aspartame t-Aspartame
-mg/dl
- 98 121 55 1"4
264 134 71 29
105 113 49 61
95 60 53
143 43 79 148
136 125 "0 68
— t 106 114 88
179 221 155 60
48 158 64 162
133.5±23.2* 127.6±17.7 79.4±11.1 93.7+17.
Glucose 144 68 IDS 163
161 128 172 178
182 189 184 166
167 142 150
136 135 106 148
218 152 120 17S
132 162 295
164 162 126 104
112
160.5±11.2
148
136. 8±12.2
178
144. 2±10.2
136
168.7+17.
'Results are expressed as means +_ SEM for 9 rats in each group.
tCould not draw blood from these rats.
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ABSTRACT
The primary objective of this study was to determine if changes
in tissue lipid levels which normally accompany exercise in rats are
affected by aspartame feeding. Wistar male weanling rats were as-
signed to a 2 x 2 factorial design (n=9) where the main treatment
effects were treadmill exercise (24 meters/min for 75 min/day, 5x/wk,
9 wks) , and aspartame feeding (0.6% in a nutritionally adequate puri-
fied diet)
.
At the end of the 9-week trial, exercised rats gained less weight,
had lower percent body fat, lighter fat pads (epididymal, retroperito-
neal, and abdominal), less intramuscular fat (vastus lateralis, vastus
medialis, and gastrocnemius lateralis), and lower serum cholesterol
and triglyceride levels. Exercised rats also consumed less feed rela-
tive to body weight throughout the trial. Aspartame-treated rats had
similar lipid contents in all tissues studied when compared to those not
receiving aspartame. However, relative feed intake was significantly
less in aspartame-fed rats.
Data suggest that aspartame feeding does not affect the changes in
tissue lipid levels which accompany exercise in rats, but that feed in-
take relative to body weight is altered.
